Skip to main content
PLOS Genetics logoLink to PLOS Genetics
. 2025 Jan 21;21(1):e1011361. doi: 10.1371/journal.pgen.1011361

SEM-2/SoxC regulates multiple aspects of C. elegans postembryonic mesoderm development

Marissa Baccas 1, Vanathi Ganesan 1, Amy Leung 1, Lucas R Pineiro 1, Alexandra N McKillop 1, Jun Liu 1,*
Editor: Barth D Grant2
PMCID: PMC11785321  PMID: 39836649

Abstract

Development of multicellular organisms requires well-orchestrated interplay between cell-intrinsic transcription factors and cell-cell signaling. One set of highly conserved transcription factors that plays diverse roles in development is the SoxC group. C. elegans contains a sole SoxC protein, SEM-2. SEM-2 is essential for embryonic development, and for specifying the sex myoblast (SM) fate in the postembryonic mesoderm, the M lineage. We have identified a novel partial loss-of-function sem-2 allele that has a proline to serine change in the C-terminal tail of the highly conserved DNA-binding domain. Detailed analyses of mutant animals harboring this point mutation uncovered new functions of SEM-2 in the M lineage. First, SEM-2 functions antagonistically with LET-381, the sole C. elegans FoxF/C forkhead transcription factor, to regulate dorsoventral patterning of the M lineage. Second, in addition to specifying the SM fate, SEM-2 is essential for the proliferation and diversification of the SM lineage. Finally, SEM-2 appears to directly regulate the expression of hlh-8, which encodes a basic helix-loop-helix Twist transcription factor and plays critical roles in proper patterning of the M lineage. Our data, along with previous studies, suggest an evolutionarily conserved relationship between SoxC and Twist proteins. Furthermore, our work identified new interactions in the gene regulatory network (GRN) underlying C. elegans postembryonic development and adds to the general understanding of the structure-function relationship of SoxC proteins.

Author summary

SoxC transcription factors play important roles in metazoan development. Abnormal expression or function of SoxC factors has been linked to a variety of developmental disorders and cancers. It is therefore critical to understand the functions of SoxC proteins in vivo. C. elegans has a single SoxC transcription factor, SEM-2, which is known to regulate a fate decision between a proliferative progenitor cell vs. a terminally differentiated cell during postembryonic mesoderm development. In this study, we report new functions of SEM-2 in postembryonic mesoderm development via our studies of a partial loss-of-function allele of sem-2. Our work uncovers new regulatory relationships between SEM-2/SoxC and the FoxF/C transcription factor LET-381, and between SEM-2/SoxC and the C. elegans Twist ortholog HLH-8. Our findings suggest that the SoxC-Twist axis, including the downstream targets of Twist, represents an evolutionarily conserved regulatory cassette important in metazoan development.

Introduction

Metazoan development is characterized by the specification and diversification of multipotent cells, as well as the proper organization of their differentiated descendants. These processes require well-orchestrated interplay between cell-intrinsic transcription factors and cell-cell signaling. The C. elegans postembryonic mesoderm, the M lineage, offers a unique model system to dissect the underlying regulatory logic of cell fate specification and diversification. The M lineage is derived from a single multipotent precursor cell, the M mesoblast [1]. During hermaphrodite postembryonic development, the M mesoblast cell undergoes stereotypical divisions to produce fourteen striated body wall muscles (BWMs), two non-muscle coelomocytes (CCs), and two multipotent sex myoblasts (SMs) that subsequently proliferate to produce sixteen sex muscles—four type I and four type II vulval muscles (vm1s and vm2s), as well as four type I and four type II uterine muscles (um1s and um2s)—that are required for egg laying (Fig 1A–1B).

Fig 1. The sem-2(P158S) mutants exhibit multiple defects during postembryonic development.

Fig 1

A) Diagram of the C. elegans hermaphrodite postembryonic mesoderm, M lineage, showing all differentiated cell types that arise from the M mesoblast cell, as well as the expression patterns of key factors critical for CC and SM fate specification in early M lineage development, based on previous publications [4,68,24,59,60]. a, anterior; p, posterior; d, dorsal; v, ventral; l, left; r, right. B) Schematic of developing C. elegans hermaphrodites showing the locations of M lineage cells. C) Model showing how SEM-2 is involved in SM vs. CC fate specification based on previous publications [4,68,24,59,60]. D) An L4 sma-9(0) animal that has four embryonic coelomocytes (arrowheads) labelled by CC::gfp. E–F) Two L4 sem-2(jj152[P158S]); sma-9(0) animals that have four embryonic CCs (arrowheads) and one (E) or two (F) M-CCs (arrows). G) A wild-type gravid adult hermaphrodite. H) A sem-2(jj152[P158S]) gravid adult hermaphrodite with a uterus filled with late-stage embryos, showing the Egl phenotype. I) The vulva (asterisk) region of a wild-type gravid adult hermaphrodite. J) A sem-2(jj321[P158S]) gravid adult hermaphrodite with two vulvae (asterisks). J) Orientation of all animals shown in this and subsequent figures. Scale bars in D-H represent 100 μm, while scale bars in I and J represent 50 μm.

Previous studies have identified multiple transcription factors and signaling components essential for the proper development of the M lineage [2]. In particular, LIN-12/Notch signaling is known to function upstream of the single C. elegans SoxC protein, SEM-2, to specify the SM fate in the ventral M lineage, while the zinc finger transcription factor SMA-9 antagonizes BMP signaling to specify the M lineage-derived CC (M-CC for short) fate in the dorsal side [36]. SMA-9 functions by activating the expression of the sole FoxF/C transcription factor in C. elegans, LET-381, in the M-CC mother cells. LET-381 then directly activates the expression of the Six homeodomain transcription factor, CEH-34, where LET-381 and CEH-34 function in a feedforward manner to directly activate the expression of genes required for CC differentiation and function [7,8]. At the same time, SMA-9 and LET-381 are each known to repress the expression of sem-2 in the dorsal side of the M lineage to prevent it from specifying the SM fate [6].

In addition to the factors described above that are important for proper fate specification in the M lineage, the sole C. elegans Twist ortholog, HLH-8, is known to function in proper patterning of the M lineage. HLH-8 is a basic helix-loop-helix (bHLH) transcription factor that is expressed in the undifferentiated cells of the M lineage through regulatory elements located in the promoter, and it is expressed in the vulval muscles by autoregulation through E boxes located in its first intron [9,10]. HLH-8 is known to have multiple functions during M lineage development: proper cleavage orientation of M lineage cells, proper proliferation of the SMs, and proper differentiation and function of the vulval muscles [11,12].

In this study, we provide new insight into the relationships between various factors important in M lineage development and the sole SoxC transcription factor SEM-2. SoxC proteins are Sry-related HMG box (Sox)-containing transcription factors that are known to play critical roles in multiple developmental processes [13]. There are three highly conserved SoxC proteins in vertebrates, Sox4, Sox11, and Sox12. Abnormal expression or function of SoxC factors has been linked to a variety of developmental disorders and cancers [1318]. In particular, mutations in Sox4 and Sox11, most of them being point mutations in the HMG box, are associated with a developmental disorder called Coffin-Siris syndrome (CSS) [1921]. However, the underlying molecular mechanisms are not completely understood.

We identified a new allele of sem-2, jj152, which is a point mutation resulting in a single amino acid change in a highly conserved residue at the end of the DNA-binding domain of SEM-2. We present genetic evidence showing that this single amino acid change results in a partial loss of SEM-2 function. By analyzing the M lineage phenotypes of jj152 mutants, we uncovered an unexpected role of SEM-2 in the dorsal M lineage, where SEM-2 functions antagonistically at the level of expression and function with LET-381 in CC specification. We also found that SEM-2 regulates the expression of hlh-8, possibly directly, in the SMs, and that SEM-2 is essential for the proliferation and the diversification of the SMs. Our work uncovered new interactions in the gene regulatory network underlying C. elegans postembryonic development, some of which are likely conserved in other species, and we add to the general understanding of the functions and structure-function relationship of SoxC proteins.

Materials and methods

C. elegans strains and transgenic lines

C. elegans strains used in this study were maintained at 20°C under normal culture conditions [22]. Analyses of hlh-8 reporters in sem-2(jj152), sem-2(jj321), sem-2(jj382 jj417) and sem-2(jj476) were performed at 25°C unless specifically noted. All strains are listed in S1 Table.

Microscopy

Epifluorescence and differential interference contrast (DIC) microscopy was conducted on a Leica DMRA2 compound microscope equipped with a Hamamatsu Orca-ER camera using the iVision software (Biovision Technology). Subsequent image analysis was performed using Fiji [23]. For comparison of fluorescence intensities in different genetic backgrounds, images were collected at the same magnification and exposure.

Statistical analysis

Statistical significance was determined by performing unpaired two-tailed Student’s t-tests or ANOVA with Dunnett’s test using Prism10 (https://www.graphpad.com/features). Raw data for all statistical analysis are available in S1 Data.

Isolation and mapping of sem-2(jj152)

sem-2(jj152) was isolated in a large-scale sma-9(cc604) Susm screen (suppression of the sma-9(cc604) M lineage defect) for the restoration of M-derived CCs in sma-9(cc604) mutants [5]. The sma-9(cc604) allele is a nonsense mutation that is considered a genetic null [24] and referred to as sma-9(0). jj152 was mapped to chromosome I using the whole genome sequencing approach described in Liu et al. [5]. Because jj152 animals are egg-laying defective (Egl), we performed complementation tests between jj152 and each of the two previously studied sem-2 alleles, n1343 and ok2422 [6]. All jj152/n1343 trans-heterozygotes are Egl, but they did not exhibit the Susm phenotype. To perform a complementation test between jj152 and ok2422, hT2[bli-4(e937) let-?(q782) qIs48(myo-2p::gfp; pes-10p::gfp; ges-1p::gfp)] (I;III)/jj152 (I); jjIs3900(hlh-8p::NLS::mCherry::lacZ + myo-2p::mCherry) (IV)/+; sma-9(0) (X) males were mated with hT2[bli-4(e937) let-?(q782) qIs48(myo-2p::gfp; pes-10p::gfp; ges-1p::gfp)] (I;III)/sem-2(ok2422) (I); sma-9(0) (X) hermaphrodites. Red, non-green jjIs3900(hlh-8p::NLS::mCherry::lacZ + myo-2p::mCherry) (IV)/+; jj152/sem-2(ok2422) (I); sma-9(0) (X) cross progeny were scored for CC number. This cross scheme ensures the unambiguous identification of jj152/sem-2(ok2422); sma-9(0) animals from the cross because 50% of the cross progeny will be jjIs3900(hlh-8p::NLS::mCherry::lacZ + myo-2p::mCherry) (IV)/+, which will have a red pharynx. Among these red cross progeny, the non-green animals will have the jj152/sem-2(ok2422) (I) genotype for the sem-2 locus due to the lack of the hT2[bli-4(e937) let-?(q782) qIs48(myo-2p::gfp; pes-10p::gfp; ges-1p::gfp)] (I;III) balancer chromosome. Most jjIs3900/+; jj152/sem-2(ok2422); sma-9(0) cross progeny were dead as embryos. Among those that survived, all (8/8) were Egl and exhibited the Susm phenotype.

Suppression of the sma-9(0) M lineage defect (Susm) assay

For the Susm assay, animals containing a CC::gfp marker (see S1 Table) were grown at 20°C to the young adult stage. The number of animals with four, five, or six CCs were tallied for each genotype. Statistical significance was calculated by performing unpaired two-tailed Student’s t-tests.

Assays for brood size and embryonic lethality

Brood size and embryonic lethality were scored under the Nikon SMZ1500 fluorescence stereo microscope. Single L4 animals were placed onto NGM plates and allowed to produce progeny at 20°C. To score the brood size of wild-type N2 animals, the parent was transferred to a new plate every 24 hours for a total of 3 days, and the eggs and newly hatched L1 larvae on each plate were counted. To score the brood size of the Egl strains, the total number of eggs present in the bagged parent and newly hatched larvae on the plate were counted 24–48 hours post-plating. To assess embryonic lethality, the progeny of all strains were allowed to grow to adulthood, and the total number of adults was noted and compared with the corresponding brood size of each parent. The average brood size and embryonic lethality were calculated for each strain. Statistical significance between the mutant strains and wild-type N2 worms was calculated by performing unpaired two-tailed Student’s t-tests.

Plasmids

All plasmids generated in this study and their purposes are described in S2 Table. pMDB28 (the homologous repair template used to generate endogenous gfp::2xflag::sem-2) was generated by performing Gibson Assembly with sem-2 genomic sequences amplified from N2 worms, the sequence of gfp amplified from pDD282 [25], a gBlock containing 2xflag purchased from Integrated DNA technologies (IDT), and a pBSII/SK+ vector digested with BamHI and HindIII. pMDB37 (the homologous repair template for generating hlh-8(jj422[hlh-8p::hlh-8::sl2::nls::gfp::nls::hlh-8 3’UTR])) was generated by performing Gibson Assembly with hlh-8 genomic sequences amplified from N2 worms, a gBlock with the gpd-2 intergenic region and nuclear localization sequence from CEOPX036 [26], the sequence of gfp amplified from pDD282 [25], another nuclear localization signal introduced by primer MDB-87, and a pBSII/SK+ vector digested with BamHI and HindIII.

pAYL11, pAYL21–pAYL25, and pAYL31–pAYL35 (hlh-8 promoter deletion constructs) were generated using pJKL502 in the 1999 Fire Lab Vector Kit as the original template. pJKL502 contains a 1.3kbp fragment (-1.3kbp to -1bp) of the hlh-8 promoter driving gfp expression. As a starting point, deletions were made at either the 5’ or 3’ end of a 517bp fragment (-517bp to -1bp) of the hlh-8 promoter, which was previously shown to be sufficient to drive M lineage expression [9]. These fragments contained HindIII and XbaI restriction sites at their ends and were used to replace the promoter region in pJKL502. Next, the 50bp internal deletion constructs, pAYL21–pAYL25, were generated by ligating the promoter elements from a 5’ deletion construct and a 3’ deletion construct, thus resulting in a set of constructs each missing a contiguous 50 bp sequence of the hlh-8 517bp promoter. Constructs that contain 20bp deletions in the -300bp to -200bp region, pAYL31–pAYL35, were generated by a two-step bridging/fusion PCR scheme where PCR fragments containing an overlapping 20bp region were used as templates for a second round of PCR to bridge the two fragments together. The resulting fragments (flanked by HindIII and XbaI sites) were subcloned to replace the promoter region in pJKL502 in the same way as described for the 5’ and 3’ deletion constructs. All plasmids were confirmed by Sanger sequencing.

CRISPR

CRISPR experiments were conducted either by using plasmids expressing regular Cas9 (pDD162) [25] or the VQR variant of Cas9 (pRB1080) [27] and plasmids expressing sgRNAs in the pRB1017 backbone [28], or by injecting ribonuclear RNP complexes with Cas9 protein, tracer RNA (from IDT), and sgRNA as described in Beacham et al. [29] (sequences listed in S3 Table). For large insertions, plasmid repair templates (S2 Table) were used, while ssDNA oligos (S3 Table) were used as repair templates to introduce point mutations. For injections, pRF4(rol-6(d)) [30] was used as a co-injection marker. Injected animals were singled onto NGM plates seeded with OP50 bacteria. Plates that gave the most roller progeny were selected for screening by PCR. Final CRISPR edits were confirmed by Sanger sequencing.

RNAi

The plasmids for let-381(RNAi) and ceh-34(RNAi) were obtained from the Ahringer RNAi library [31] and confirmed by sequencing. RNAi was conducted by following the protocol of Amin et al. [7]. Synchronized L1 animals of various genotypes were plated on HT115(DE3) bacteria expressing dsRNA against the gene of interest, allowed to grow at 25°C, and scored for M lineage phenotypes 12–48 hours after plating. Bacteria carrying the L4440 empty vector was used as a negative control.

Results

A sem-2 allele, jj152, suppresses the sma-9(0) M lineage phenotype in coelomocyte specification

In a sma-9(0) suppressor screen to identify new factors involved in M lineage development [5], we identified a mutation, jj152, on chromosome I. jj152 animals showed partial suppression of the sma-9(0) M lineage (Susm) phenotype: 41.2% of jj152; sma-9(0) animals (N = 767) have 1–2 M-CCs, instead of zero M-CCs in sma-9(0) single mutant (Fig 1D–1F, Table 1). jj152 animals are also 100% egg-laying defective (Egl), have a smaller brood size than wild-type (WT), display ~25% embryonic lethality and exhibit a 6.9% bivulva (Biv) phenotype (N = 360) (Fig 1G–1J, Table 2). Unlike sma-9(0) mutants, which have a small body size and lack both M-CCs, jj152 single mutants are not small, and all jj152 mutants have 1–2 M-CCs (Table 1).

Table 1. The sem-2(P158S) mutation suppresses the sma-9(cc604) missing M-derived coelomocyte (CC) phenotype.

Genotype % 1–2 M-CCsa % Egl No. of animals
sem-2(jj152) 100 100 845
sma-9(cc604) 1.4 - 1359b
sem-2(n1343); sma-9(cc604) 0.59% 100 1672
sem-2(jj152); sma-9(cc604) 41.2*** 100 767
sem-2(jj152); sma-9(cc604); jjIs1647[sem-2(+)] 0 ND 0 329
sem-2(ok2422)/+; sma-9(cc604) 2.4ND 0 205
sem-2(ok2422)/sem-2(jj152); sma-9(cc604) 100*** 100 8c

a CCs were scored using the CC::gfp described in S1 Table.

b Data from Liu et al. (2022) [5].

c Most sem-2(ok2422)/sem-2(jj152); sma-9(cc604) animals are embryonic lethal, with only few animals able to survive through larval development to become young adults, which is when we score the M-CC phenotype. Genotyping four of the eight animals confirmed that they are jj152/ok2422. Details of the complementation tests are described in Materials and Methods.

ND: no difference

***: P<0.001, when compared to sma-9(cc604) animals based on unpaired two-tailed Student’s t-test.

Table 2. The sem-2(P158S) mutation results in reduced brood size, increased embryonic lethality, and an egg-laying defective phenotype.

Genotype % Egl (n) Brood size (n) % Emb (n)
WT 0 (>100) 303 ± 26.7 (9) 0 (2582)
sem-2(jj152) 100 (>100) 32.4 ± 8.3 (11)*** 17.2 ± 9.7 (314)***
sem-2(jj320) 100 (>100) 41.9 ± 5.5 (10)*** 20.97 ± 8.4 (419)***
sem-2(jj321) 100 (>100) 37.3 ± 5.2 (10)*** 30.31 ± 9.2 (373)***
sem-2(ok2422) N/A N/A 100***a

Egl: egg-laying defective; Emb: embryonic lethal.

The average brood size and average percentage of Egl or Emb ± standard deviation are presented in this table. Details on scoring the brood size and embryonic lethality are described in Materials and Methods.

n, number of worms scored. For brood size, n reflects the number of parents singled and their brood sizes scored.

***: P<0.001 when compared to WT based on unpaired two-tailed Student’s t-test. N/A: not applicable.

a data from Tian et al. 2011 [6].

Several lines of evidence suggest that jj152 is an allele of sem-2: 1) whole genome sequencing revealed that jj152 maps to chromosome I and contains a cytosine (C) to thymine (T) nucleotide change, which results in a proline (P) to serine (S) residue change in amino acid 158 (P158S) of SEM-2 (Fig 2A–2B); 2) jj152 failed to complement the sem-2(ok2422) null allele in both the Egl and the Susm phenotypes (Tables 1 and 2); 3) a transgene carrying a fosmid containing the wild-type sem-2 genomic sequences (jjIs1647[sem-2(+)], [6]) rescued both the Susm and the Egl phenotypes of jj152 mutants (Tables 1 and 2); and 4) CRISPR-engineered sem-2(P158S) mutations in the wild-type background, sem-2(jj320) and sem-2(jj321), recapitulated the mutant phenotypes exhibited by jj152 animals (Tables 1 and 2). Given that jj152, jj320, and jj321 mutants exhibit a weaker phenotype than sem-2(ok2422) null or trans-heterozygous mutants (Tables 12), or animals that have undergone postembryonic sem-2(RNAi) [6], we concluded that the SEM-2(P158S) mutant protein exhibits a partial loss of SEM-2 function.

Fig 2. The sem-2(P158S) mutation does not affect the expression, localization, or level of the SEM-2 protein.

Fig 2

A) [Top] Schematic of the SEM-2 protein with the DNA-binding domain in yellow, the serine-rich region in red, and the transactivation domain (TAD) in purple. The P158S mutation is indicated by an asterisk. [Bottom] Sequence alignment of part of the DNA-binding domain of SEM-2 with SoxC proteins in different vertebrate species. Residue P158 is conserved in all SoxC proteins shown and is highlighted by a green box. B) Structural model of the SEM-2 DNA-binding domain (yellow) with DNA (tan), based on the structure of the Mouse Sox4 DNA-binding domain-DNA complex (PDB code 3U2B [33]. Residue P158 is highlighted in green. C–D) Fluorescence images showing the expression patterns of the endogenously tagged GFP::2xFLAG::SEM-2 (C) and GFP::2xFLAG::SEM-2(P158S) (D) in hermaphrodites at the L3 stage. Arrows point to the migrating SMs in the focal plane. Scale bar represents 40 μm. E) Quantification of GFP::2xFLAG::SEM-2 fluorescence intensity in hypodermal nuclei of WT (sem-2(jj382)) and sem-2(P158S) (sem-2(jj417)) animals. Three nuclei per animal were measured. Each dot represents a nucleus. Data are normalized to WT. Statistical significance was calculated by performing unpaired two-tailed Student’s t-tests. ns, not significant.

The single amino acid change in sem-2(jj152), P158S, does not drastically affect the localization or level of SEM-2 protein

We were intrigued by the Susm phenotype of sem-2(jj152[P158S]) because sem-2(n1343), which has a Tc1 transposon insertion that disrupts sem-2 expression in the SM lineage and exhibits a SM to BWM fate transformation phenotype, does not show any Susm phenotype (Table 1, [6]). We therefore decided to further explore the impact of the sem-2(jj152[P158S]) point mutation on SEM-2 function, and the relationship between sem-2 and sma-9 in M-CC fate specification.

sem-2 encodes the sole SoxC protein in C. elegans, whereas vertebrates have three SoxC proteins, Sox4, Sox11, and Sox12 [32]. SoxC proteins have a conserved DNA-binding domain, a serine-rich region, and a transactivation domain (Fig 2A). Amino acid P158 is located near the end of SEM-2’s DNA-binding domain and is conserved in SoxC homologs from vertebrates (Fig 2A). Structural modeling based on the co-crystal structure of mouse Sox4 and its cognate DNA showed that P158 is located in a flexible linker region of the domain but does not directly touch DNA (Fig 2B, [33]). It is likely that the P158S mutation alters the conformation of SEM-2, thus affecting its DNA-binding affinity or its affinity to other factors that function together with SEM-2.

To begin to assess the functional consequences of the P158S mutation on SEM-2 protein, we tagged SEM-2 at the endogenous locus with GFP::2xFLAG using CRISPR. This endogenously tagged SEM-2 is functional as GFP::2xFLAG::SEM-2 animals are viable, fertile, and non-Egl. As shown in Fig 2C, GFP::2xFLAG::SEM-2 is nuclear localized in many different cell types, such as cells of the hypodermis, intestine, vulva and pharynx, similar to what we have previously reported using transgenic animals expressing a GFP-tagged SEM-2 in a fosmid backbone [6]. To determine if the P158S mutation affects SEM-2 expression, localization, or stability, we used CRISPR and introduced the P158S mutation into the endogenously tagged GFP::2xFLAG::SEM-2, and generated sem-2(jj382 jj417[GFP::2xFLAG::SEM-2(P158S)]. As shown in Fig 2C–2E, SEM-2(P158S) exhibits a similar pattern and level of expression and localization to the wild-type SEM-2 protein. Considering the structural information shown in Fig 2B, we concluded that the P158S mutation likely affects the activity of the SEM-2 protein. This prediction is consistent with our genetic evidence suggesting that SEM-2(P158S) is partially functional.

sem-2 exhibits dynamic expression patterns in the postembryonic M lineage

Having an endogenously tagged GFP::2xFLAG::SEM-2 allowed us to more accurately assess the expression pattern of sem-2 in the M lineage. Consistent with our previous report based on transgenic animals expressing GFP::SEM-2 in a fosmid backbone [6], endogenous GFP::2xFLAG::SEM-2 expression is detectable in the SM mothers, the SMs, and throughout the SM lineage in all SM descendants before they terminally differentiate (Fig 3E–3K”). Surprisingly, strong nuclear GFP::2xFLAG::SEM-2 signal is detectable in the M mesoblast, and it remains detectable, but becomes progressively fainter, in all M lineage cells up to the 16-M stage (Fig 3A–3E”). At the 16-M stage, GFP::2xFLAG::SEM-2 signal is significantly brighter in the SM mother cells (M.vlpa and M.vrpa) (Figs 3E–3E” and S1G). At the 18-M stage when the BWMs and CCs are born and become terminally differentiated, GFP::2xFLAG::SEM-2 is only detectable in the two SMs (M.vlpaa and M.vrpaa) and transiently in the SM sister cells (M.vlpap and M.vrpap) before they terminally differentiate into BWMs (Fig 3F–3F”). At all stages of M lineage development when GFP::2xFLAG::SEM-2 is detectable, there is GFP signal in both the nucleus and the cytoplasm. The intensity of both nuclear and cytoplasmic GFP signals exhibit a gradual decrease during the two proliferative phases of M lineage development (in the early M lineage and in the SM lineage) (S1 Fig). Moreover, the level of GFP::2xFLAG::SEM-2 fluorescence intensity in the SM cells is significantly higher than in the M cell (S1 Fig). The expression and localization pattern of GFP::2xFLAG::SEM-2 in the M lineage is quantified and summarized in Figs 3L and S1.

Fig 3. Endogenously tagged GFP::2xFLAG::SEM-2 exhibits dynamic expression throughout the M lineage.

Fig 3

A–K”) Fluorescence images showing the expression of GFP::2xFLAG::SEM-2 (A’–K’) in M lineage cells of hermaphrodites labelled by the hlh-8p::nls::mCherry reporter (A–K) at different stages of M lineage development, with the corresponding merged images shown in A”–K”. The SM sisters (M.vlpap and M.vrpap) migrate posteriorly after they are born and become BWMs [1]. Only the left side of an animal is shown in A–K”. The other side is out of the focal plane. YA, young adult. Scale bar represents 20 μm for A–J” and 10 μm for K–K”. L) Summary of GFP::2xFLAG::SEM-2 expression in the M lineage, based on quantification of nuclear GFP intensity shown in S1 Fig. Cells represented by the light green color have lower levels of GFP::2xFLAG::SEM-2 expression than cells represented by the dark green color. Circles with black outline represent terminally differentiated cells that do not express GFP::2xFLAG::SEM-2.

To determine if the P158S mutation affects the expression and/or localization of SEM-2 specifically in the M lineage, we compared the expression and localization pattern of wild-type GFP::2xFLAG::SEM-2 with mutant GFP::2xFLAG::SEM-2(P158S) (S2 Fig). At the 1-M stage, we detected a slight increase in nuclear GFP intensity as well as nuclear to cytoplasmic ratio in sem-2(P158S) mutants compared to wild-type animals (S2C and S2E Fig). However, there is no difference in SEM-2 level or localization in the SMs when comparing wild-type and sem-2(P158S) mutant animals (S2F–S2L Fig).

SMA-9 specifically represses the dorsal M lineage expression of GFP::2xFLAG::SEM-2 at the stage of CC and SM fate specification

We have previously shown that SMA-9 represses the expression of SEM-2 in the dorsal M lineage at the 18-M stage when the SMs are born [6]. Given the unexpected Susm phenotype of sem-2(jj152[P158S]) and the unexpected expression of endogenous GFP::2xFLAG::SEM-2 in the early M lineage prior to the birth of SMs, we sought to determine if the expression level or pattern of GFP::2xFLAG::SEM-2 changes in the M lineage of sma-9(0) mutants. Consistent with our previous report, we observed expression of endogenous GFP::2xFLAG::SEM-2 in the SM-like cells in the dorsal M lineage of sma-9(0) animals (Fig 4B–4B”’). However, we did not detect any difference in the expression level or pattern of GFP::2xFLAG::SEM-2 between WT and sma-9(0) animals from the 1-M to the 8-M stage (S3 Fig). These results suggest that SMA-9 functions to repress the dorsal M lineage expression of sem-2 only at the stage of CC and SM fate specification.

Fig 4. SMA-9 and LET-381 repress sem-2 expression in the dorsal M lineage, while ectopically expressed SEM-2 represses let-381 expression in the dorsal M lineage.

Fig 4

A–D”) Fluorescence images showing GFP::2xFLAG::SEM-2 (A’–D’) in M lineage cells labelled by the hlh-8p::nls::mCherry reporter (A–D) at different stages of M lineage development in WT (A–A”), sma-9(0) (B–B”), let-381(RNAi) (C–C”), and ceh-34(RNAi) (D–D”) hermaphrodites. A”–D” are corresponding merged images. A”’–D”’) Schematic representation of the fluorescence images. Green circles represent cells expressing GFP::2xFLAG::SEM-2. Green circles with thick, black outlines are SMs. Green circles with thin, black outlines represent SM sisters fated to become BWMs. The cell with thick, burnt orange outline is an SM mother (C”’). E–H”) Fluorescence images showing mNG::LET-381 (E’–H’) in M lineage cells labelled by the hlh-8p::nls::mCherry reporter (E–H) at different stages of M lineage development in WT (E–E”), sem-2(jj476[P158S]) (F–F”), sma-9(0) (G–G”), and sem-2(jj476[P158S]); sma-9(0) (H–H”) hermaphrodites. (E”–H”) are corresponding merged images. E”’–H”’) Schematic representation of the fluorescence images. Blue circles represent CC cells expressing mNG::LET-381. Circles with thick, black outlines are SMs that have migrated to the future vulva region. Yellow asterisks label the SM cells (M.vlpaa); yellow unshaded arrowheads label the SM sister cells (M.vlpap), which are BWMs; yellow number sign labels the SM mother cell (M.vlpa); yellow arrows label the SM-like cells born in the dorsal side of the M lineage in sma-9(0) (B’, G) or let-381(RNAi) (C’) hermaphrodites; yellow, shaded arrowheads label the CC cells (M.dlpa) in WT (E–E’), sem-2(jj476[P158S]) (F–F’), and sem-2(jj476[P158S]); sma-9(0) (H–H’) hermaphrodites. The fluorescence intensity of the hlh-8p::nls::mCherry reporter is significantly reduced in animals carrying the sem-2(jj476[SEM-2(P158S)] mutation and was adjusted individually for panels F and H for cell identification. The intensity of the hlh-8p::nls::mCherry reporter is hereafter not comparable, unless specifically noted. Only the left side of an animal is shown in this figure, while the other side is out of the focal plane. Scale bars represent 20 μm.

SEM-2 antagonizes the function of LET-381 in specifying M-derived CCs by repressing let-381 expression

As described above, when the fully functional SEM-2 is ectopically expressed in the dorsal M lineage of sma-9(0) single mutants, no M-CCs are produced. However, around 40% of sem-2(jj152[P158S]); sma-9(0) double mutants have 1–2 M-CCs. The forkhead transcription factor LET-381/FoxF/C is known to function downstream of SMA-9 and upstream of the Six homeodomain transcription factor CEH-34, where LET-381 and CEH-34 function in a feedforward manner to specify the M-CC fate [7,8]. We therefore hypothesized that the Susm phenotype of sem-2(jj152[P158S]) might be because the partially functional SEM-2(P158S) protein, when ectopically expressed in the dorsal side of the M lineage at the 16-M stage, cannot fully inhibit either the expression or the function of let-381.

To test the above hypothesis, we examined the expression pattern of an endogenously tagged mNG::LET-381 [34] in WT, sma-9(0), and sem-2(jj476[P158S]); sma-9(0) animals. Since sem-2 and let-381 are located close to each other on Chromosome I (sem-2 at -0.27 while let-381 at +1.02), we used CRISPR to introduce the P158S mutation into the let-381(dev205[mNG::LET-381]) strain and generated the sem-2(jj476[P158S]) let-381(dev205[mNG::LET-381]) strain. We then conducted genetic crosses and generated the sem-2(jj476[P158S]) let-381(dev205[mNG::LET-381]); sma-9(0) strain. Similar to the previously reported pattern of expression for the LET-381::GFP transgene [8], endogenous mNG::LET-381 is expressed in the dorsal M-CC mothers (M.dlp and M.drp) and the CCs (M.dlpa and M.drpa) in WT animals (100%, N = 40) (Fig 4E–4E”’) and in sem-2(jj476[P158S]) single mutants (98%, N = 50, Fig 4F–4F”’), while this M lineage expression disappears in sma-9(0) mutants (98.3%, N = 59) (Fig 4G–4G”’). Instead, 65.9% of sem-2(jj476[P158S]) let-381(dev205 [mNG::LET-381]); sma-9(0) mutants examined (N = 41) showed expression of mNG::LET-381 in M.dlpa and/or M.drpa (Fig 4H–4H”’), cells that are normally fated to become CCs. Consistent with this finding, the M-CCs formed in sem-2(jj152[P158S]); sma-9(0) double mutants require LET-381. As shown in Table 3, while 24.6% of sem-2(jj152[P158S]); sma-9(0) animals on control RNAi with the empty vector L4440 (N = 240) had 1–2 M-CCs, only 3.1% of sem-2(jj152[P158S]) let-381(RNAi); sma-9(0) animals (N = 291) had M-CCs. Taken together, the above findings demonstrate that SEM-2 antagonizes the function of LET-381 in specifying M-derived CCs by repressing let-381 expression.

Table 3. LET-381 is required for the formation of M-derived CCs in sem-2(jj152); sma-9(cc604) double mutants.

Genotype RNAia % with no
M-CCsb
% with 1–2
M-CCs
No. of animals
WT L4440 7.6 92.2 437c
WT let-381 93.4 6.6 412
sem-2(jj152) L4440 0.7 99.3 431
sem-2(jj152) let-381 92.1 7.9 350
sem-2(jj152); sma-9(cc604) L4440 75.4 24.6 240
sem-2(jj152); sma-9(cc604) let-381 96.9 3.1 291

a Postembryonic RNAi as described in Materials and Methods.

b CCs were scored using the CC::gfp described in S1 Table.

c One of the 437 animals scored had 3 M-CCs.

LET-381, but not CEH-34, represses the expression of SEM-2 in dorsal M lineage cells fated to become CCs

We have previously shown that in let-381(RNAi) animals, CCs are transformed to SM-like cells in the dorsal side of the M lineage [8], and that LET-381 represses the expression of the GFP::SEM-2 transgene in the dorsal M lineage cells fated to become M-CCs [6]. We found that this result holds true for the endogenously tagged GFP::2xFLAG::SEM-2, as let-381(RNAi) animals had GFP::2xFLAG::SEM-2 ectopically expressed in the dorsal M lineage cells that are normally fated to become M-CCs (Fig 4C–4C”’).

Because LET-381 and CEH-34 function in a feedforward manner to specify M-CCs, we also examined the expression pattern of GFP::2xFLAG::SEM-2 in ceh-34(RNAi) animals. As shown in Fig 4D–4D”’, ceh-34(RNAi) animals did not exhibit any ectopic expression of GFP::2xFLAG::SEM-2 in the dorsal M lineage. This is consistent with CEH-34 functioning downstream of LET-381 for specifying M-CCs [7,8]. Thus, LET-381, but not CEH-34, functions to repress sem-2 expression in cells fated to become M-CCs.

SEM-2 regulates the expression of hlh-8 in the M lineage

During our analysis of the mechanistic basis of the Susm phenotype of sem-2(P158S) mutants, we noticed that sem-2(P158S) mutants exhibit significantly reduced levels of expression of the transgenic hlh-8 transcriptional reporter jjIs3900[hlh-8p::nls::mCherry] (Figs 5 and S4). In wild-type animals, hlh-8p::nls::mCherry is expressed in the M mesoblast and all undifferentiated cells in the M lineage from the 1-M to 16-SM stage. The sem-2(jj321[P158S]) mutants display reduced expression of this reporter at all stages of M lineage development (100%, N = 234) (Figs 5A–5F and S4A–S4C). Similar reduction of hlh-8p::nls::mCherry expression was observed in the M lineage of sem-2(jj152[P158S]) mutants (100%, N = 643). Moreover, the expression of another hlh-8 transcriptional reporter ayIs6[hlh-8p::gfp] [9] is also reduced in sem-2(jj152[P158S]) mutants (100%, N = 599) (S4D–S4G Fig). Thus, the expression of two independent, transgenic, hlh-8 transcriptional reporters is significantly reduced in sem-2(jj152[P158S]) mutants.

Fig 5. SEM-2 regulates hlh-8 expression in the M lineage.

Fig 5

A–C) Fluorescence images (A–B) of wild-type (A–A”) and sem-2(jj321[P158S]) (B–B”) L1 animals showing expression of hlh-8p::nls::mCherry in the M mesoblast cell. A’–B’ and A”-B” are corresponding DIC and merged images, respectively. C) Quantification of hlh-8p::nls::mCherry expression level in the M mesoblast of wild-type and sem-2(jj321[P158S]) L1 animals. Each dot represents a nucleus. Data are normalized to WT. D–F) Fluorescence images (D–E) of wild-type (D–D”) and sem-2(jj321[P158S]) (E–E”) L3 animals showing expression of hlh-8p::nls::mCherry in SMs. D’–E’ and D”–E” are corresponding DIC and merged images, respectively. F) Quantification of hlh-8p::nls::mCherry expression in the SMs of wild-type and sem-2(jj321[P158S]) L3 animals. Each dot represents a nucleus. Data are normalized to WT. For panels A–E, fluorescence images of the same staged animals were captured at the same exposure and magnification. G–I) Fluorescence images (G’–H’) of wild-type (G–G”) and sem-2(jj321[P158S]) (H–H”) L1 animals showing expression of mNG::MLS-2 in the M mesoblast labelled by the hlh-8p::nls::mCherry reporter (G–H). Arrows point to the M mesoblast cell, while arrowheads point to the SM cell. There is an increase in background signal in panels H and H” because a longer exposure time was used due to the reduced expression level of hlh-8p::nls::mCherry in sem-2(P158S) mutants. I) Quantification of mNG::MLS-2 in the M mesoblast cell of wild-type and sem-2(jj321[P158S]) animals. Each dot represents a nucleus. Data are normalized to WT. Statistical significance was calculated by performing unpaired two-tailed Student’s t-tests. **** P<0.0001, *** P<0.001, ns, not significant. Scale bars represent 10 μm.

To determine if the reduced expression of hlh-8 in sem-2(P158S) mutants is specific to the hlh-8 gene in the M lineage, we examined the expression of mls-2 in sem-2(jj321[P158S]) mutants using an endogenously tagged mNG::MLS-2 [35]. MLS-2 is a NK homeodomain protein that regulates patterning, cell fate specification, and proliferation in the early M lineage [36]. mls-2 is expressed starting at the 1-M stage in the M lineage [36]. We found no change in expression level or pattern of mNG::MLS-2 in sem-2(jj321[P158S]) mutants compared to WT (Fig 5G–5I). These results suggest that SEM-2 specifically regulates the expression of hlh-8 in the M lineage.

To determine if the change in hlh-8 expression was specific to the sem-2(P158S) allele, we introduced jjIs3900[hlh-8p::nls::mCherry] into sem-2(ok2422) null mutants. The majority of sem-2(ok2422) null mutants produced by heterozygous sem-2(ok2422)/hT2[qIs48] mothers die as threefold embryos, while a few embryos can hatch but die as L1 larvae [6]. We found that 83.3% sem-2(ok2422) embryos (N = 12) express hlh-8p::nls::mCherry in the M mesoblast cell at similar levels as sem-2(ok2422)/hT2[qIs48] control embryos (92.9%, N = 14) (S4H–S4J Fig). However, none of the sem-2(ok2422) L1 animals (100%, N = 14) display any detectable hlh-8p::nls::mCherry expression, unlike the sem-2(ok2422)/hT2[qIs48] control L1s where most of them show bright hlh-8p::nls::mCherry expression in the M mesoblast cell (98.1%, N = 52) (S4K–S4L”’ Fig). One possible reason why there is more robust expression of hlh-8p::nls::mCherry in sem-2(ok2422) null embryos than in sem-2(jj321[P158S]) embryos is maternal contribution of SEM-2 in the sem-2(ok2422) null embryos by sem-2(ok2422)/hT2[qIs48] parents (S4A–S4C and S4H–S4J Fig). Further, these results suggest that SEM-2 is required for maintaining stable hlh-8 expression in the M lineage.

SEM-2 is required for endogenous hlh-8 expression in the M lineage

To determine if SEM-2 is required for endogenous hlh-8 expression in the M lineage, we generated an endogenous hlh-8 transcriptional reporter using the strategy described in Luo et al. [37]. Using CRISPR, we inserted the intergenic trans-splicing acceptor region from CEOPX036 followed by nls::gfp::nls at the end of the hlh-8 coding region. The resulting hlh-8(jj422[hlh-8::sl2::nls::gfp::nls]) (denoted jj422[hlh-8p::gfp]) is a bicistronic allele where hlh-8 and gfp are co-transcribed under the hlh-8 promoter (Fig 6A), and expression of nuclear localized GFP is indicative of endogenous hlh-8 expression. Animals expressing this endogenous hlh-8 transcriptional reporter do not exhibit any overt phenotypes exhibited by hlh-8(0) mutants [12], suggesting that hlh-8 function is not compromised in jj422[hlh-8p::gfp] animals. The GFP signal of this endogenous hlh-8 transcriptional reporter is rather faint, yet it has the same expression pattern as the transgenic jjIs3900[hlh-8p::nls::mCherry] and ayIs6[hlh-8p::gfp] reporters in the M lineage (Fig 6B–6D”).

Fig 6. SEM-2 is required for endogenous hlh-8 expression in the M lineage.

Fig 6

A) Schematic representation of an endogenous hlh-8 transcriptional reporter generated by introducing a sl2 spliced leader sequence from CEOPX036 and the sequence of nls::gfp::nls at the end of the HLH-8 coding region. This reporter hlh-8(jj422[hlh-8::sl2::nls::gfp::nls]) is denoted jj422[hlh-8p::gfp]. Gray boxes represent hlh-8 exons with introns separating them. The orange color indicates the sl2 sequence, the blue color indicates the nuclear localization signal (nls), and the green color indicates gfp. B–D”) Fluorescence images showing the expression of jj422[hlh-8p::gfp] (B’–D’), the transgenic jjIs3900[hlh-8p::nls::mCherry] (B–D), and corresponding merged images (B”–D”) in the M lineage at the 1-M (B–B”), 2-SM (C–C”), and 8-SM (D–D”) stages. jj422[hlh-8p::gfp] has the same expression pattern as the transgenic jjIs3900[hlh-8p::nls::mCherry], but the jj422[hlh-8p::gfp] signal in the M mesoblast cell is faint. Arrow in B’ points to the M mesoblast cell. E–H) Fluorescence images (E’–G’) of wild-type (E–E”) and sem-2(jj321[P158S]) (F–G”) L3 animals showing expression of jj422[hlh-8p::gfp] in SMs labelled by the transgenic hlh-8p::nls::mCherry reporter (E–G). Merged images are shown in E”–G”. Scale bars represent 10 μm. H) Quantification of the number of SMs in wild-type and sem-2(jj321[P158S]) animals that express jj422[hlh-8p::gfp]. I) Quantification of GFP fluorescence intensity in jj422[hlh-8p::gfp]-expressing SM cells in WT and sem-2(jj321[P158S]). Each dot represents an animal scored. Data are normalized to WT. Statistical significance was calculated by performing unpaired two-tailed Student’s t-tests. * P<0.05.

We then examined the expression of the endogenous hlh-8 transcriptional reporter in sem-2(jj321[P158S]) mutants. The expression of jj422[hlh-8p::gfp] in the early M lineage is too faint to make accurate comparisons between WT and sem-2(jj321[P158S]). At the SM stage, the expression level of jj422[hlh-8p::gfp] was significantly reduced in at least one of the two SMs in sem-2(jj321[P158S]) mutants (81.0%, N = 42) compared with wild-type animals that express sem-2 in both SMs (94.3%, N = 35) (Fig 6E–6H). Similarly, in 50% of sem-2(jj321[P158S]) animals, jjIs3900[hlh-8p::nls::mCherry] is undetectable in one of two SMs (N = 26), whereas wild-type animals always have detectable expression in the SMs (100%, N = 24) (S2F–S2I” Fig). We quantified the expression of jj422[hlh-8p::gfp] in the sem-2(jj321[P158S]) SMs that expressed it, and found that sem-2(jj321[P158S]) animals exhibit reduced expression of jj422[hlh-8p::gfp] compared to wild-type animals (Fig 6I). Thus, based on data using both the transgenic and endogenous hlh-8 transcriptional reporters, SEM-2 is required to regulate hlh-8 expression in the M lineage.

sem-2(P158S) mutants exhibit abnormal expression of several HLH-8 direct target genes and have defects in SM proliferation and egg-laying muscle differentiation

HLH-8 is known to directly, but differentially, regulate the expression of several reporter genes in the M lineage, including egl-15p::gfp (expressed in vm1s), arg-1p::gfp (expressed in all vms), and NdEbox::gfp (expressed in all vms and ums) [911,38,39]. Because hlh-8 expression is reduced in sem-2(P158S) mutants, we asked whether these sem-2 mutants exhibited altered expression of HLH-8 target genes. As shown in Fig 7A–7B’, while 100% WT animals had arg-1p::gfp expression in vms (N = 30) or egl-15p::gfp in vm1s (N = 100), only 1.6% of sem-2(jj321[P158S]) mutants examined (N = 63) expressed arg-1p::gfp in the vms. Further, while 95% sem-2(jj321[P158S]) mutants expressed the vm1 marker egl-15p::rfp (N = 138) (Fig 7A’–7A”), there was a significant reduction of the number of egl-15p::rfp-positive cells in sem-2(jj321[P158S]) mutants (Fig 7A” and 7F), and these cells appeared deformed (Fig 7A–7A”). Moreover, the fluorescence intensity of egl-15p::rfp in sem-2(jj321[P158S]) mutants was slightly reduced compared to WT animals (Fig 7G). In addition, fewer cells in sem-2(jj321[P158S]) mutants expressed NdEbox::gfp, although the expression level of Ndebox::gfp appeared unchanged in the cells that expressed it (100%, N = 25) (Figs 7D–7D’ and 7H). Thus, sem-2(P158S) mutants exhibit abnormal expression of target genes directly regulated by HLH-8.

Fig 7. sem-2(P158S) mutants have reduced numbers and deformed egg-laying muscles.

Fig 7

A–E’) Images of wild-type (A–E) and sem-2(jj321[P158S]) mutant (A’–E’) gravid adult animals (A–C”) or L4 animals (D–E’) showing the expression of egl-15p::rfp and hlh-29p::gfp (A’–A”), arg-1p::gfp (B–B’), rgs-2p::gfp (C–C”), NdEbox::gfp (D–D’) and hlh-8p::nls::mCherry (E–E’). sem-2(jj321[P158S]) mutants either have no (A’) or a reduced number of egg-laying muscles expressing hlh-29p::gfp (A”), with no change in hlh-29p::gfp expression in the spermatheca (SP). sem-2(jj321[P158S]) mutants also have either reduced expression (A’) or a reduced number of egg-laying muscles expressing egl-15p::gfp (A”). arg-1p::gfp expression is completely lost in the vms, but remains in the head mesodermal cell (HMC) and the enteric muscles (EMs), of sem-2(jj321[P158S]) mutants (compare B and B’). sem-2(jj321[P158S]) mutants also have either no expression (C”) or a reduced number of cells (C’) expressing the um marker rgs-2p::gfp, with no change in its expression in the nerve cord. At the L4 larval stage, sem-2(jj321[P158S]) mutants have reduced number of cells expressing NdEbox::gfp and hlh-8p::nls::mCherry (D’–E’) compared to WT (D–E). F–H) Graphs showing the number of vm1s and vm2s as indicated by the expression of egl-15p::rfp (vm1s) and hlh-29p::gfp (vm2s) (F), the expression level of egl-15p::rfp (G), and the number of Ndebox::gfp-expressing cells (H) in wild-type and sem-2(jj321[P158S]) animals. Each dot represents an animal scored. Data are normalized to WT in panel G. Statistical significance was calculated by performing unpaired two-tailed Student’s t-tests. **** P<0.0001. * P<0.05, Scale bars represent 40 μm.

HLH-8 is known to regulate the proper proliferation of the SMs, and the proper differentiation and function of the vulval muscles [11,12]. Consistent with a role of SEM-2 in regulating the expression of hlh-8, sem-2(P158S) mutants also exhibited defects in SM proliferation and vulval and uterine muscle differentiation. While sem-2(jj321[P158S]) mutants have two SMs, as indicated by the expression of the endogenously tagged GFP::2xFLAG::SEM-2 in sem-2(jj382 jj417[GFP::2xFLAG::SEM-2(P158S)] animals (92%, N = 25) (S2H–S2I” Fig), the SMs do not divide at the wild-type rate (Fig 8A–8G). At the young to mid- L4 larval stage when wild-type animals have 16 SM descendants, sem-2(jj417[P158S]) mutants have fewer than 16 cells resembling SMs in the developing vulva region (Figs 8A–8G and 7E–E’). Consistent with an SM proliferation defect, only 28% of sem-2(jj321[P158S]) mutants (N = 139) expressed the vm2 marker hlh-29p::gfp [40], and 50% of sem-2(jj321[P158S]) mutants (N = 20) expressed the um marker rgs-2p::gfp [41]. We further monitored the M lineage division patterns in WT and sem-2(P158S) mutants and found that the mutants exhibit variable patterns of reduced SM proliferation. Fig 8G summarizes the different types of SM division patterns observed in sem-2(jj321[P158S]) mutants. Thus, SEM-2 is required for the proper proliferation of the SMs and the differentiation of the various egg-laying muscles.

Fig 8. sem-2(P158S) mutants have SM proliferation defects.

Fig 8

Fluorescence and DIC images showing SMs and SM descendants labelled by hlh-8p::nls::mCherry (A–F) and GFP::2xFLAG::SEM-2 (A’–F’) in wild-type (sem-2(jj382[GFP::2xFLAG::SEM-2])) (A–A”’, C–C”’, E–E”’) and sem-2(P158S) (sem-2(jj382 jj417[GFP::2xFLAG::SEM-2(P158S)])) mutant (B–B”’, D–D”’, F–F”’) animals at the L3 (A–B”’), young L4 (C–D”’), and mid L4 (E–F”’) stages. Corresponding merged and DIC images are shown in A”–F” and A”’–F”’, respectively. Asterisks label SMs and SM descendants. Scale bar represents 20 μm. G) Schematic representations of the SM lineage division patterns in WT and sem-2(P158S) mutants. Total number of animals scored was 26 for WT and 40 for sem-2(P158S).

A putative SoxC-binding site is critical for hlh-8 promoter activity in the M lineage

To determine if SEM-2 directly regulates hlh-8 expression and to also identify regions in the hlh-8 promoter that are important for expression in the M lineage, we performed transgenic reporter assays by generating a series of deletion constructs in the hlh-8 promoter and testing the ability of each deleted hlh-8 promoter to drive GFP expression in the M lineage. As shown in Fig 9A–9H”, we uncovered two 20bp regions required for hlh-8 promoter activity in the M lineage: one between -280bp and -260bp, which we named E1, and another between -220bp and -200bp, which we named E2 (Figs 9A–9H” and S5A). E1 is highly conserved among multiple nematode species (S5A Fig), and it contains a putative Sox transcription factor binding site, which we named Site1, based on the transcription factor binding site identifier PROMO (https://alggen.lsi.upc.edu). The consensus sequence for SoxC binding is CA/TTTGTT (S5B Fig) [13, 42, 43]. Site1 contains the exact sequence for SoxC binding AACAAAGaagaag and is located at -272bp to -259bp upstream of the hlh-8 start codon (S5 Fig). E2 has a sequence that matches the consensus sequence for SoxC binding by 6 out of 7 nucleotides (CTTTCTTttc), which we named Site2. Site2 is located at -221bp to -211bp upstream of the hlh-8 start codon (S5 Fig).

Fig 9. Two 20bp regions in the hlh-8 promoter are necessary for hlh-8 promoter activity in the M lineage.

Fig 9

A) Schematics of the wild-type construct and 50bp deletions in a hlh-8 transgenic transcriptional reporter that has 517bp of the hlh-8 promoter located immediately upstream of its start codon driving the expression of gfp. B) Schematics of hlh-8 transcriptional reporter constructs with 20bp deletions in a 100bp region located at -300bp to -200bp upstream of the start codon of hlh-8. E1 and E2 contain putative SEM-2/SoxC-binding sites and are indicated by the color magenta. C–E”) Representative fluorescence images of reporter expression (C’–H’) in the M mesoblast cell of L1 animals (C–E”) and in SMs of L3 animals (F–H”) labelled by the hlh-8p::nls::mCherry reporter (C–H). C”–H” are merged images. Scale bars represent 20 μm.

We then tested the importance of the putative SoxC-binding sites in Site1 and Site2 in vivo, by mutating Site1 alone (because it contains an exact match to the SoxC binding consensus) or Site1 and Site2 together in the endogenous hlh-8 transcriptional reporter background, jj422[hlh-8p::gfp]. We generated three alleles: jj483 jj422 [hlh-8p(Site1m+Site2m)::gfp], which has a 13bp mutation with the putative SoxC-binding site in Site1 mutated and a 10bp mutation with the putative SoxC-binding site in Site2 mutated, as well as jj445 jj422 [hlh-8p(Site1m)::gfp] and jj446 jj442 [hlh-8p(Site1m)::gfp], both of which have a 13bp mutation with the putative SoxC-binding site in Site1 mutated (Fig 10A, S1 and S3 Tables). All three alleles resulted in reduced or undetectable levels of GFP in the SMs: jj483 jj422 [hlh-8p(Site1m+Site2m)::gfp] have undetectable levels of GFP in 97.4% of SMs scored (N = 39), jj445 jj422 [hlh-8p(Site1m)::gfp] and jj446 jj442 [hlh-8p(Site1m)::gfp] have undetectable levels of GFP in 96.1% of SMs scored (N = 52). In contrast, wild-type animals have detectable levels of GFP in 99% of all the SMs scored (N = 96). The few animals carrying Site1 and Site2 mutations (jj483) or only Site 1 mutations (jj445/jj446) that expressed jj422[hlh-8p::gfp] in the SMs had significantly reduced expression compared to wild-type animals. These results indicate that the putative SoxC-binding site in Site1 is important for hlh-8 expression in the M lineage. Intriguingly, jj422[hlh-8p::gfp] expression at the 16-SM stage in the three mutants appeared comparable to that in wild-type animals (Fig 10E–10G”), suggesting that mutating the putative SoxC-binding sites significantly reduces, but does not completely abolish, hlh-8 expression in the M lineage. Consistent with this notion, none of these three mutants exhibited an Egl phenotype, a hlh-8 null-like phenotype. We reasoned that there might be additional SoxC-binding site(s) in the endogenous hlh-8 genomic region that contributes to the activation of hlh-8 expression in the absence of the two putative SoxC-binding sites in Site1 and Site2. Alternatively, hlh-8 expression in the later stages of M lineage development does not depend on SEM-2.

Fig 10. A putative SEM-2/SoxC-binding site is important for robust endogenous hlh-8 expression in the M lineage.

Fig 10

A) A schematic showing mutations made in two putative SEM-2/SoxC-binding sites in the hlh-8 promoter in worms carrying an endogenous hlh-8 transcriptional reporter, jj422[hlh-8p::gfp]. The sequences of E1 (20bp region identified in Fig 9) and E2 (20bp region identified in Fig 9) are listed. The putative SEM-2/SoxC-binding sites are highlighted in yellow. Site1 (13bp) and Site2 (10bp) are underlined in red. Mutations in Site1 and/or Site2 in (hlh-8(jj483 jj422)) and (hlh-8(jj445/446 jj422)) are indicated by lowercase letters. B–D”) Fluorescence images (B’–D’) of a wild-type (hlh-8(jj422)) (B–B”), a Site1 and Site2 mutant (hlh-8(jj483 jj422)) (C–C”), and a Site1 mutant (hlh-8(jj445 jj422)) (D–D”) L3 animal showing expression of jj422[hlh-8p::gfp] in SMs labelled by the hlh-8p::nls::mCherry reporter (B–D). Merged images are shown in B”–D”. jj483 jj422 [hlh-8p(Site1m+Site2m)::gfp] have undetectable levels of GFP in 97.4% (N = 39) of SMs scored, jj445 jj422 [hlh-8p(Site1m)::gfp] and jj446 jj442 [hlh-8p(Site1m)::gfp] have undetectable levels of GFP in 96.1% of SMs scored (N = 52), while wild-type animals have detectable levels of GFP in 99% (N = 96) of SMs scored. E–G”) Fluorescence images (E’–G’) of a wild-type (hlh-8(jj422)) (E–E”), a Site1 and Site2 mutant (hlh-8(jj483 jj422)) (F–F”), and a Site1 mutant (hlh-8(jj446 jj422)) (G–G”) animals showing expression of jj422[hlh-8p::gfp] in SM descendants labelled by the hlh-8p::nls::mCherry reporter (E–G). Merged images are shown in E”–G”. Scale bars represent 10 μm.

Discussion

By taking advantage of a partial loss-of-function allele of sem-2, we have identified additional functions of the single C. elegans SoxC protein, SEM-2, and uncovered previously unappreciated regulatory relationships between SEM-2 and LET-381/FoxF/C, as well as between SEM-2 and HLH-8/Twist. Our work adds new subcircuits to the gene regulatory network underlying C. elegans postembryonic development [2].

SEM-2/SoxC functions antagonistically with LET-381/FoxF/C in CC fate specification

The zinc finger transcription factor SMA-9/Schnurri is known to regulate the expression of the forkhead transcription factor LET-381/FoxF/C, and both proteins are required for specifying the M-CC fate in the dorsal M lineage. Loss of either transcription factor results in a fate transformation of M-CCs to SMs due to de-repression of sem-2 expression [8,24]. In this study, we have found that the sem-2(P158S) mutation, which renders the SEM-2 protein partially functional, can suppress the loss of M-CC phenotype of sma-9(0) mutants (Susm), and that this Susm phenotype is dependent on the presence of LET-381 (Tables 1 and 3, Fig 4). These findings support a role of SEM-2 in the dorsal side of the M lineage and a mutually repressive relationship between SEM-2 and LET-381 (Fig 11A). We therefore propose a model shown in Fig 11A. Based on this model, in wild-type animals, SMA-9 functions, either acting through or independently of LET-381, to repress sem-2 expression in the presumptive CC mothers (M.dlp and M.drp) and CCs (M.dlpa and M.drpa) in the dorsal M lineage (Fig 11A). The expression of let-381 in M.dlpa and M.drpa then leads to the activation of ceh-34 expression, where LET-381 and CEH-34 function in a feedforward manner to regulate M-CC specification and function [8]. In sma-9(0) single mutants, ectopic expression of a fully functional sem-2 in the dorsal M lineage leads to the repression of let-381 expression in the presumptive CCs, causing the transformation of these cells to SMs (Fig 11B). sem-2(P158S) single mutants look like wild-type animals regarding CC specification, because of the actions of SMA-9 and LET-381 in preventing sem-2 expression in the dorsal M lineage (Fig 11C). In sem-2(P158S); sma-9(0) double mutants, the partially functional SEM-2(P158S) protein being expressed in the dorsal side of the M lineage is not sufficient to fully repress let-381 expression, leading to the expression of let-381 and the formation of M-CCs in a fraction of these double mutant animals (Fig 11D). This model is consistent with our previous findings that forced expression of sem-2 throughout the M lineage leads to the conversion of M derived-CCs and BWMS to SMs [6]. Moreover, it adds the possibility that SMA-9 activates let-381 expression by way of repressing sem-2 expression, forming a double negative gate. Future work will aim to determine whether SEM-2 and LET-381 directly regulate each other’s expression in the M lineage.

Fig 11. A model on the regulatory network involved in CC specification in the dorsal M lineage.

Fig 11

In WT animals (A), LET-381 is expressed in the dorsal M lineage cells fated to become CCs due to the presence of SMA-9 in these cells, either by repressing the expression of sem-2, thus preventing SEM-2 from repressing the expression of LET-381, or by activating let-381 expression independently of SEM-2. Once expressed, LET-381 further represses the expression of sem-2, while at the same time, directly activates the expression of CEH-34 and functions in a feedforward manner with CEH-34 to activate genes required for the differentiation and function of CCs. In sma-9(0) mutants (B), the de-repression of SEM-2 expression leads to the conversion of CCs to SMs as the fully functional SEM-2 represses let-381 expression. The partially functional SEM-2 protein expressed in sem-2(P158S) mutants (SEM-2*) on its own (C) is not expected to affect the CC fate. However, in sma-9(0) mutants, the de-repressed expression of a partially functional SEM-2(P158S) protein (SEM-2*) is not sufficient to completely repress LET-381 expression, thus leading to a fraction of sem-2(P158S); sma-9(0) double mutants producing CCs in the dorsal M lineage (D). Dotted line in panel D indicates that the SEM-2(P158S) protein (SEM-2*) is not able to fully repress let-381 expression.

The repression of sem-2 expression in the M lineage by SMA-9 appears to be stage-specific, as sem-2 expression in the early M lineage (1-M stage to 8-M stage) does not change in sma-9(0) mutants (S3 Fig). SMA-9 does not appear to be the only factor repressing sem-2 expression in the non-SM cells at the 16- to 18-M stage. We have previously shown that HLH-1 and FOZI-1 repress sem-2 expression in the M-derived BWMs, and that this genetic interaction is reciprocal, as SEM-2 is known to repress the expression of hlh-1 and fozi-1 in the SM mother cells and the SMs [6]. Similarly, expression of sem-2 in the SM mother cells and the SMs requires LIN-12/Notch signaling and the zinc finger transcription factor SEM-4 [6,44], implicating additional levels of complexity in the regulatory network underlying proper fate specification in the M lineage. It is clear that the specification of M-CCs and SMs involves intricate gene regulatory networks that include both positive and negative feedback, feedforward, and mutually antagonistic regulatory subcircuits. As previously suggested [45], such regulatory logic ensures temporal and spatial specificity of gene expression and robust cell fate specification.

SEM-2/SoxC is necessary for the specification, proliferation, and differentiation of the SMs and SM descendants

Previous studies have shown that SEM-2 specifies the multipotent and proliferative SM fate [6]. Since the SMs are not made in sem-2(n1343) mutants that were used in the previous study, we could not determine if SEM-2 plays a role beyond SM specification in the SM lineage. In most sem-2(P158S) mutants, the level of functional SEM-2 in the M lineage is sufficient to specify the SM fate (92%, N = 25) (S2F–S2I” Fig). However, the SMs in sem-2(P158S) mutants exhibit reduced proliferation. These results provide direct evidence supporting a role of SEM-2 in regulating cell proliferation. It is possible that SEM-2 functions upstream of, and/or works cooperatively with, certain cell cycle regulators, either through positive regulation of G1/S-phase cyclins (Cyclin D/CDK4, Cyclin E/CDK2) or negative regulation of CDK inhibitors like CKIs (CKI-1/CKI-2) [4651]. This role of SEM-2 in regulating cell proliferation appears to be evolutionarily conserved. Sox4, one of the SoxC proteins in humans, is often amplified and overexpressed in multiple cancers, and Sox4 is known to play crucial roles in cancer development and progression, and has been classified as a “cancer signature” gene [16,18].

In addition to regulating SM specification and proliferation, SEM-2 is essential for the proper differentiation of multiple non-striated muscle cells derived from the SM lineage. We have shown that while the vm1-specific reporter (egl-15p::rfp) is expressed in over 90% of sem-2(P158S) mutants, a significantly smaller fraction of sem-2(P158S) mutant animals express the vm2-specific reporter (hlh-29p::gfp, 28%), the um-specific marker (rgs-2p::gfp, 50%), or another vm marker (arg-1p::gfp, 1.6%) (Fig 7). These findings suggest that SEM-2 is important for the proper differentiation of the various non-striated muscles derived from the SM lineage. The more prevalent expression of the vm1-specific reporter (egl-15p::rfp) in sem-2(P158S) mutants is similar to our previous report showing that in lin-39(0) mab-5(0) mutants where the M lineage exhibits reduced cell proliferation, the few M lineage cells precociously differentiate to express the vm1 marker egl-15p::gfp, but not vm2 or um markers [52]. This shared, reduced proliferation phenotype by lin-39(0) mab-5(0) mutants and sem-2(P158S) mutants is consistent with MAB-5 and LIN-39 directly activating the expression of SEM-2 in the M lineage [6].

The SoxC-Twist axis as a conserved regulatory cassette in metazoan development

Multiple lines of evidence support the role of SEM-2 in regulating the expression of hlh-8/Twist in the M lineage, possibly directly. First, both transgenic hlh-8 transcriptional reporters (hlh-8p::gfp and hlh-8p::nls::mCherry) and an endogenous hlh-8 transcriptional reporter all exhibited significantly reduced expression in sem-2(P158S) mutants (Figs 5 and 6). Moreover, the sem-2(P158S) mutant phenotype is similar to the hlh-8 mutant phenotype. Both sem-2(P158S) mutants and hlh-8 null, nr2061, mutants are Egl due to missing vulval muscles (this study, [12]). Additionally, animals with a semidominant allele of hlh-8, n2170 (E29K), have SMs that often fail to divide [11], a phenotype similar to the SM proliferation defect in the sem-2(P158S) mutants. Finally, sem-2(P158S) mutants exhibit reduced, yet differential, expression of several HLH-8 target genes, such as egl-15p::gfp and arg-1p::gfp, a phenotype that has been previously observed in various hlh-8 mutants. For example, several hlh-8 point mutants (R103M, R103A, L95F and F99L) express egl-15p::gfp, but do not express arg-1p::gfp, in the vulval muscles [39]. Similarly, worms containing hlh-8(tm726), a 646-nucleotide deletion at the 3’ end of intron one, express egl-15p::gfp (15% of animals) but do not express arg-1p::gfp [10], whereas animals that are heterozygous for hlh-8(n2170) express arg-1p::gfp but do not express egl-15p::gfp [11]. These results are consistent with altered or reduced endogenous hlh-8 expression in sem-2(P158S) mutants.

It is likely that SEM-2 directly regulates the expression of hlh-8 in the M lineage, through at least one of the putative SoxC-binding sites (Site1) in the hlh-8 promoter (Figs 10A and S5). We have shown that E1, a 20bp region containing Site1, is essential for hlh-8 promoter activity in transgenic reporter assays, and Site1 is important for hlh-8 expression in the endogenous genomic environment (Figs 9 and 10). Mutating the putative SoxC-binding sites in Site1 and Site2 significantly reduced, but did not completely abolish, hlh-8 expression in the endogenous locus, possibly due to the presence of other putative SoxC-binding sites in the hlh-8 genomic region. Nevertheless, our results collectively are consistent with SEM-2 playing an important, likely a direct, role in regulating the expression of hlh-8 in the M lineage.

In humans Twist1, Twist2, FGFRs and JAG-1/Notch2 are known to play important roles in craniofacial development [53, 54]. The C. elegans homolog of Twist1/2 is HLH-8, the homolog of the FGFRs is EGL-15, and the homolog of JAG-1 is ARG-1 [11,39,55]. egl-15 and arg-1 are direct targets of HLH-8, and they have each been shown to be expressed in and/or to work in patterning a subset of mesodermal tissues: the egg-laying muscles and the enteric muscles [11,12]. Mutations in hlh-8 and egl-15 lead to Egl and/or Con phenotypes, which have been labelled as phenologs of craniofacial defects in humans [39]. The sem-2(P158S) mutants are 100% Egl (Fig 1G–1H, Table 1). Intriguingly, mutations in SoxC proteins, Sox4 and Sox11, are associated with a developmental disorder called Coffin-Siris syndrome (CSS), and one key characteristic of CSS patients is craniofacial defects [1921]. Similarly, SoxC proteins are known to function upstream of Twist1, in some cases directly, in disease initiation and progression in mammals, particularly in the regulation of epithelial-mesenchymal transition (EMT) [16,5658]. Thus, the SoxC-Twist axis, including the downstream targets of Twist, such as FGFRs and JAG-1, represents an evolutionarily conserved regulatory cassette important in metazoan development.

Supporting information

S1 Table. C. elegans strains used in this study.

(DOCX)

pgen.1011361.s001.docx (21.7KB, docx)
S2 Table. Plasmids generated in this study.

(DOCX)

pgen.1011361.s002.docx (17.1KB, docx)
S3 Table. Oligonucleotides used in this study.

(DOCX)

pgen.1011361.s003.docx (18.6KB, docx)
S1 Fig. Quantification of GFP::2xFLAG::SEM-2 expression during M lineage development.

A–C) Quantification of GFP::2xFLAG::SEM-2 fluorescence intensity in the nuclei (A, D, G), the cytoplasm (B, E, H), and the ratio of nuclear signal to cytoplasmic signal (C, F, I) in the early M lineage (A, B, C), the SM lineage (D, E, F), and throughout M lineage development (G, H, I). All images were taken at the same exposure and same magnification. Each dot represents a cell scored. Data for GFP::2xFLAG::SEM-2 expression at the 16-M stage in M-derived BWMs and SM mother cells are denoted 16-M(B) and 16-M(S), respectively. For graphs D-I, only data for the SMs at the 18-M stage are shown. For panels C, F, and I, the ratios were calculated by dividing the nuclear GFP intensity by the cytoplasmic GFP intensity. For panels A–C, data were normalized to the 1-M stage. For panels D–I, data were normalized to the 18-M stage. Statistical analysis was done using one-way ANOVA with Dunnett’s test. **** P<0.0001, *** P<0.001, ** P<0.01, * P<0.05, ns, not significant. All the corresponding data shown in panels A-C and D-F were combined and shown in panels G-I. To prevent the graph from being too crowded, only P values not shown in panels A-F are shown in G-I. There is a gradual decrease in the level of nuclear GFP::2xFLAG::SEM-2 in the early M lineage after the 2-M stage (A). At the 16-M stage, there is an upregulation of nuclear GFP::2xFLAG::SEM-2 in the SM mothers (A). At the 18-M stage, this increase in nuclear GFP::2xFLAG::SEM-2 persists in the SMs but becomes undetectable in the BWMs (including in the SM sister cells, which transiently express GFP::2xFLAG::SEM-2) upon terminal differentiation. There is then a gradual decrease in the level of nuclear GFP::2xFLAG::SEM-2 signal in the SM descendants (D). The level of cytoplasmic GFP::2xFLAG::SEM-2 signal appears relatively stable within the early M lineage (B), and within the SM lineage (E). The ratio of nuclear to cytoplasmic localization of GFP::2xFLAG::SEM-2 in the M lineage follows the pattern of change of nuclear GFP::2xFLAG::SEM-2 (C, F, I). There is an increase in the level of nuclear and cytoplasmic GFP::2xFLAG::SEM-2, as well as their ratio, in the SMs at the 18-M stage compared with the M mesoblast cell at the 1-M stage (G, H, I).

(TIF)

pgen.1011361.s004.tif (3.3MB, tif)
S2 Fig. Quantification of GFP::2xFLAG::SEM-2 expression in the M lineage of wild-type and SEM-2 P158S mutant animals.

A–B”) Fluorescence images showing GFP::2xFLAG::SEM-2 (A’–B’) in the M mesoblast cell labelled by the hlh-8p::nls::mCherry reporter (A–B) at the 1-M stage in WT (A–A”) and sem-2(jj417[SEM-2 P158S]) (B–B”) hermaphrodites. (A”–B”) are the corresponding merged images. The GFP::2xFLAG::SEM-2 images were taken at the same exposure and same magnification. C–E) Quantification of GFP::2xFLAG::SEM-2 in the nuclei (C), the cytoplasm (D), and the ratio of nuclear to cytoplasmic signal (E) in the M mesoblast cell of wild-type and sem-2(jj417[SEM-2 P158S]) animals. F–I”) Fluorescence images of a wild-type (sem-2(jj382)) animal (F–G”) and a sem-2(jj417[P158S]) mutant animal (H–I”), showing GFP::2xFLAG::SEM-2 (F’–I’), hlh-8p::nls::mCherry (F–I), and the corresponding merged images (F”–I”) in the two SMs. All GFP::2xFLAG::SEM-2 images were taken at the same exposure and same magnification, while hlh-8p::nls::mCherry images in H and I were taken using a longer exposure than those in F and J. J–L) Quantification of GFP::2xFLAG::SEM-2 in the nuclei (J), the cytoplasm (K), and the ratio of nuclear to cytoplasmic signal (L) in the SMs of wild-type and sem-2(jj417[SEM-2 P158S]) animals. For panels E and L, the ratios were calculated by dividing the nuclear GFP intensity by the cytoplasmic GFP intensity. Each dot represents a cell scored. Data are normalized to WT. Statistical significance was calculated by performing unpaired two-tailed Student’s t-tests. *** P<0.001, * P<0.05, ns, not significant. Scale bars represent 10 μm. Arrows point to the M mesoblast cell, while arrowheads point to the SM cell.

(TIF)

pgen.1011361.s005.tif (12.4MB, tif)
S3 Fig. sem-2 expression in the early M lineage does not change in sma-9(0) mutants.

A–D”) Fluorescence images showing GFP::2xFLAG::SEM-2 (A’–D’) in M lineage cells labelled by the hlh-8p::nls::mCherry reporter (A–D) at the 2-M stage (A–B”) and 8-M stage (C–D”) of M lineage development in WT (A–A”, C–C”) and sma-9(0) (B–B”, D–D”) hermaphrodites. (A”–D”) are the corresponding merged images. Only the left side of an animal is shown in this figure, while the other side is out of the focal plane. Scale bar represents 20 μm. E–G) Quantification of GFP::2xFLAG::SEM-2 in the nuclei (E), the cytoplasm (F), and the ratio of nuclear to cytoplasmic signal (G) in the early M lineage of WT and sma-9(0) mutants. For panel G, the ratios were calculated by dividing the nuclear GFP intensity by the cytoplasmic GFP intensity. Each dot represents a cell scored. Data are normalized to WT at the 1–2 M stage. Statistical significance was calculated by performing unpaired two-tailed Student’s t-tests. ns, not significant.

(TIF)

pgen.1011361.s006.tif (10.6MB, tif)
S4 Fig. The regulation of hlh-8 by SEM-2 is not transgene- or sem-2 allele-specific.

A–B”) Fluorescence images (A–B) of wild-type (A–A”) and sem-2(jj321[P158S]) (B–B”) embryos showing the expression of hlh-8p::nls::mCherry in the M mesoblast cell (arrows). A’–B’ and A”–B” are corresponding DIC and merged images, respectively. Transgenic animals expressing hlh-8p::nls::mCherry were generated with a co-injection marker myo-2p::mCherry represented by the red pharyngeal signal. Scale bar represents 15 μm. C) Quantification of hlh-8p::nls::mCherry expression in the M mesoblast cell of WT and sem-2(jj321[P158S]) embryos. Each dot represents an embryo scored. Data are normalized to WT. Statistical significance was calculated by performing unpaired two-tailed Student’s t-tests. * P<0.05. D–E) Fluorescence images of wild-type (D–D”) and sem-2(jj152[P158S]) (E–E”) mutant L3 animals showing expression of the hlh-8p::gfp transgene in SMs. D’–E’ and D”–E” are corresponding DIC and merged images, respectively. Exposure for panel E is 20x times higher than panel D (1x). Scale bar represents 10 μm. F–G) Fluorescence images of wild-type (F) and sem-2(jj152[P158S]) (G) mutant L1 animals at the 4-M stage showing expression of the hlh-8p::gfp transgene at the same exposure (1x). Scale bar represents 20 μm. H–I”) Fluorescence images (H–I) of a heterozygous sem-2 null (sem-2(ok2422)/hT2[qIs48]) (H–H”) and a sem-2 null (sem-2(ok2422)) (I–I”) embryo showing expression of hlh-8p::nls::mCherry. myo-2p::gfp images from the hT2[qIs48] balancer chromosome are shown in H’–I’ and merged images are shown in H”–I”. Scale bar represents 15 μm. J) Quantification of hlh-8p::nls::mCherry expression in the embryonic M mesoblast cell of sem-2(ok2422)/hT2[qIs48] and sem-2(ok2422) animals. Each dot represents an embryo scored. Data are normalized to sem-2(ok2422)/hT2[qIs48]. Statistical significance was calculated by performing unpaired two-tailed Student’s t-tests. ns, not significant. K–L”’) Fluorescence images (K–L) of a heterozygous sem-2 null (sem-2(ok2422)/hT2[qIs48]) (K–K”’) and a sem-2 null (sem-2(ok2422)) (L–L”’) L1 animals showing expression of hlh-8p::nls::mCherry. myo-2p::gfp images from the hT2[qIs48] balancer chromosome are shown in K’–L’, merged images of hlh-8p::nls::mCherry and myo-2p::gfp are shown in K”–L”, and DIC images are shown in K”’–L”’. Scale bar represents 20 μm. Arrows point to M lineage cells.

(TIF)

pgen.1011361.s007.tif (15.4MB, tif)
S5 Fig. The putative SEM-2/SoxC-binding site in E1 is conserved.

A) Screenshot of the University of California, Santa Cruz (UCSC) genome browser showing the sequence conservation of E1 and E2 in the hlh-8 promoter among 26 nematode species and a broader 135 species (112 nematodes, 22 flatworms, and Ciona intestinalis). The magenta color highlights E1 and E2. Red boxes show Site1 and Site2. The yellow color highlights the putative SEM-2/SoxC-binding sites in E1/Site1 and E2/Site2. B) The position weight matrix of the Sox4/SoxC primary motif as determined by the protein-binding microarray (PBM) method [33].

(TIF)

pgen.1011361.s008.tif (11.9MB, tif)
S1 Data. Excel file containing all the raw data for Figs 2, 5, 6, 7, S1, S2, S3 and S4.

(XLSX)

pgen.1011361.s009.xlsx (39.6KB, xlsx)

Acknowledgments

We thank Yoko Takashima for generating the sem-2(jj321); arg-1p::gfp strain, Josh Arribere, Dan Dickinson, Andy Fire, Bob Goldstein and Oliver Hobert for plasmids, Sijung Yun for analyzing whole genome sequencing data, Gunther Hollopeter for sharing CRISPR protocol, Yuxin Mao for advice on structural modeling, Peter Schweitzer and the Cornell Genomics Facility for help with whole genome sequencing assays, and members of the Liu lab for helpful discussions and critical comments on the manuscript.

Data Availability

Strains and plasmids are available upon request. The authors affirm that all data necessary for confirming the conclusions of the article are present within the article and its supporting information files.

Funding Statement

Some strains were obtained from the C. elegans Genetics Center, which is funded by National Institutes of Health (NIH) Office of 27 Research Infrastructure Programs (P40 OD-010440). This work was supported by NIH R35 GM130351 to J.L.. M.B. was partially supported by the HHMI Gilliam Fellowship for Advanced Study (#GT13366) and the Cornell IMSD, which is funded by NIH R25 GM125597. A.L. was partially funded by the Cornell University College of Agriculture and Life Sciences Charitable Trust Grant and Morley Student Research Grant. L.P. and A.N.M. were Hunter R. Rawlings III Presidential Research Scholars at Cornell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Sulston JE, Horvitz HR. Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Developmental biology. 1977;56(1):110–56. doi: 10.1016/0012-1606(77)90158-0 [pii]. [DOI] [PubMed] [Google Scholar]
  • 2.Liu J, Murray JI. Mechanisms of lineage specification in Caenorhabditis elegans. Genetics. 2023. Epub 20231017. doi: 10.1093/genetics/iyad174 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Greenwald IS, Sternberg PW, Horvitz HR. The lin-12 locus specifies cell fates in Caenorhabditis elegans. Cell. 1983;34(2):435–44. doi: 10.1016/0092-8674(83)90377-x [DOI] [PubMed] [Google Scholar]
  • 4.Foehr ML, Liu J. Dorsoventral patterning of the C. elegans postembryonic mesoderm requires both LIN-12/Notch and TGFbeta signaling. Developmental biology. 2008;313(1):256–66. doi: 10.1016/j.ydbio.2007.10.027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Liu Z, Shi H, Szymczak LC, Aydin T, Yun S, Constas K, et al. Promotion of bone morphogenetic protein signaling by tetraspanins and glycosphingolipids. PLoS Genet. 2015;11(5):e1005221. doi: 10.1371/journal.pgen.1005221 ; PubMed Central PMCID: PMC4433240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Tian C, Shi H, Colledge C, Stern M, Waterston R, Liu J. The C. elegans SoxC protein SEM-2 opposes differentiation factors to promote a proliferative blast cell fate in the postembryonic mesoderm. Development (Cambridge, England). 2011;138(6):1033–43. doi: 10.1242/dev.062240 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Amin NM, Lim SE, Shi H, Chan TL, Liu J. A conserved Six-Eya cassette acts downstream of Wnt signaling to direct non-myogenic versus myogenic fates in the C. elegans postembryonic mesoderm. Developmental biology. 2009;331(2):350–60. doi: 10.1016/j.ydbio.2009.05.538 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Amin NM, Shi H, Liu J. The FoxF/FoxC factor LET-381 directly regulates both cell fate specification and cell differentiation in C. elegans mesoderm development. Development (Cambridge, England). 2010;137(9):1451–60. doi: 10.1242/dev.048496 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Harfe BD, Vaz Gomes A, Kenyon C, Liu J, Krause M, Fire A. Analysis of a Caenorhabditis elegans Twist homolog identifies conserved and divergent aspects of mesodermal patterning. Genes & development. 1998;12(16):2623–35. doi: 10.1101/gad.12.16.2623 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Meyers SG, Corsi AK. C. elegans twist gene expression in differentiated cell types is controlled by autoregulation through intron elements. Dev Biol. 2010;346(2):224–36. Epub 20100804. doi: 10.1016/j.ydbio.2010.07.025 ; PubMed Central PMCID: PMC2945437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Corsi AK, Brodigan TM, Jorgensen EM, Krause M. Characterization of a dominant negative C. elegans Twist mutant protein with implications for human Saethre-Chotzen syndrome. Development (Cambridge, England). 2002;129(11):2761–72. doi: 10.1242/dev.129.11.2761 [DOI] [PubMed] [Google Scholar]
  • 12.Corsi AK, Kostas SA, Fire A, Krause M. Caenorhabditis elegans twist plays an essential role in non-striated muscle development. Development (Cambridge, England). 2000;127(10):2041–51. doi: 10.1242/dev.127.10.2041 [DOI] [PubMed] [Google Scholar]
  • 13.Penzo-Mendez AI. Critical roles for SoxC transcription factors in development and cancer. The international journal of biochemistry & cell biology. 2010;42(3):425–8. doi: 10.1016/j.biocel.2009.07.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Grippa M, Graziano C. Landscape of Constitutional SOX4 Variation in Human Disorders. Genes (Basel). 2024;15(2). Epub 20240125. doi: 10.3390/genes15020158 ; PubMed Central PMCID: PMC10887744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Tsang SM, Oliemuller E, Howard BA. Regulatory roles for SOX11 in development, stem cells and cancer. Semin Cancer Biol. 2020;67(Pt 1):3–11. Epub 20200620. doi: 10.1016/j.semcancer.2020.06.015 . [DOI] [PubMed] [Google Scholar]
  • 16.Hanieh H, Ahmed EA, Vishnubalaji R, Alajez NM. SOX4: Epigenetic regulation and role in tumorigenesis. Semin Cancer Biol. 2020;67(Pt 1):91–104. Epub 20190702. doi: 10.1016/j.semcancer.2019.06.022 . [DOI] [PubMed] [Google Scholar]
  • 17.Angelozzi M, Lefebvre V. SOXopathies: Growing Family of Developmental Disorders Due to SOX Mutations. Trends Genet. 2019;35(9):658–71. Epub 20190706. doi: 10.1016/j.tig.2019.06.003 ; PubMed Central PMCID: PMC6956857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Moreno CS. SOX4: The unappreciated oncogene. Semin Cancer Biol. 2020;67(Pt 1):57–64. Epub 20190821. doi: 10.1016/j.semcancer.2019.08.027 ; PubMed Central PMCID: PMC7043201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Tsurusaki Y, Koshimizu E, Ohashi H, Phadke S, Kou I, Shiina M, et al. De novo SOX11 mutations cause Coffin-Siris syndrome. Nat Commun. 2014;5:4011. Epub 20140602. doi: 10.1038/ncomms5011 . [DOI] [PubMed] [Google Scholar]
  • 20.Hempel A, Pagnamenta AT, Blyth M, Mansour S, McConnell V, Kou I, et al. Deletions and de novo mutations of SOX11 are associated with a neurodevelopmental disorder with features of Coffin-Siris syndrome. J Med Genet. 2016;53(3):152–62. Epub 20151105. doi: 10.1136/jmedgenet-2015-103393 ; PubMed Central PMCID: PMC4789813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Zawerton A, Yao B, Yeager JP, Pippucci T, Haseeb A, Smith JD, et al. De Novo SOX4 Variants Cause a Neurodevelopmental Disease Associated with Mild Dysmorphism. Am J Hum Genet. 2019;104(4):777. doi: 10.1016/j.ajhg.2019.01.014 ; PubMed Central PMCID: PMC6451692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974;77(1):71–94. doi: 10.1093/genetics/77.1.71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676–82. doi: 10.1038/nmeth.2019 ; PubMed Central PMCID: PMC3855844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Foehr ML, Lindy AS, Fairbank RC, Amin NM, Xu M, Yanowitz J, et al. An antagonistic role for the C. elegans Schnurri homolog SMA-9 in modulating TGFbeta signaling during mesodermal patterning. Development (Cambridge, England). 2006;133(15):2887–96. doi: 10.1242/dev.02476 [DOI] [PubMed] [Google Scholar]
  • 25.Dickinson DJ, Pani AM, Heppert JK, Higgins CD, Goldstein B. Streamlined Genome Engineering with a Self-Excising Drug Selection Cassette. Genetics. 2015;200(4):1035–49. Epub 2015/06/06. doi: 10.1534/genetics.115.178335 ; PubMed Central PMCID: PMC4574250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Tursun B, Cochella L, Carrera I, Hobert O. A toolkit and robust pipeline for the generation of fosmid-based reporter genes in C. elegans. PLoS One. 2009;4(3):e4625. Epub 20090304. doi: 10.1371/journal.pone.0004625 ; PubMed Central PMCID: PMC2649505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Bell RT, Fu BX, Fire AZ. Cas9 Variants Expand the Target Repertoire in Caenorhabditis elegans. Genetics. 2016;202(2):381–8. Epub 2015/12/19. doi: 10.1534/genetics.115.185041 ; PubMed Central PMCID: PMC4788222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Arribere JA, Bell RT, Fu BX, Artiles KL, Hartman PS, Fire AZ. Efficient marker-free recovery of custom genetic modifications with CRISPR/Cas9 in Caenorhabditis elegans. Genetics. 2014;198(3):837–46. Epub 2014/08/28. doi: 10.1534/genetics.114.169730 ; PubMed Central PMCID: PMC4224173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Beacham GM, Wei DT, Beyrent E, Zhang Y, Zheng J, Camacho MMK, et al. The Caenorhabditis elegans ASPP homolog APE-1 is a junctional protein phosphatase 1 modulator. Genetics. 2022;222(1). doi: 10.1093/genetics/iyac102 ; PubMed Central PMCID: PMC9434228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Mello C, Fire A. DNA transformation. Methods in cell biology. 1995;48:451–82. [PubMed] [Google Scholar]
  • 31.Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, Gotta M, et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature. 2003;421(6920):231–7. doi: 10.1038/nature01278 [DOI] [PubMed] [Google Scholar]
  • 32.Wegner M. From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res. 1999;27(6):1409–20. doi: 10.1093/nar/27.6.1409 ; PubMed Central PMCID: PMC148332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Jauch R, Ng CK, Narasimhan K, Kolatkar PR. The crystal structure of the Sox4 HMG domain-DNA complex suggests a mechanism for positional interdependence in DNA recognition. Biochem J. 2012;443(1):39–47. doi: 10.1042/BJ20111768 . [DOI] [PubMed] [Google Scholar]
  • 34.Ma X, Zhao Z, Xiao L, Xu W, Kou Y, Zhang Y, et al. A 4D single-cell protein atlas of transcription factors delineates spatiotemporal patterning during embryogenesis. Nat Methods. 2021;18(8):893–902. Epub 20210726. doi: 10.1038/s41592-021-01216-1 . [DOI] [PubMed] [Google Scholar]
  • 35.Xiong R, Hsieh YW, Chuang CF. mNG-tagged mls-2 knock-in alleles in C. elegans. MicroPubl Biol. 2022;2022. Epub 20220222. doi: 10.17912/micropub.biology.000529 ; PubMed Central PMCID: PMC8864483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Jiang Y, Horner V, Liu J. The HMX homeodomain protein MLS-2 regulates cleavage orientation, cell proliferation and cell fate specification in the C. elegans postembryonic mesoderm. Development (Cambridge, England). 2005;132(18):4119–30. doi: 10.1242/dev.01967 [DOI] [PubMed] [Google Scholar]
  • 37.Luo KL, Underwood RS, Greenwald I. Positive autoregulation of lag-1 in response to LIN-12 activation in cell fate decisions during C. elegans reproductive system development. Development. 2020;147(18). Epub 20200928. doi: 10.1242/dev.193482 ; PubMed Central PMCID: PMC7541336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Wang P, Zhao J, Corsi AK. Identification of novel target genes of CeTwist and CeE/DA. Developmental biology. 2006;293(2):486–98. doi: 10.1016/j.ydbio.2005.10.011 [DOI] [PubMed] [Google Scholar]
  • 39.Gruss MJ O’Callaghan C, Donnellan M, Corsi AK. A Twist-Box domain of the C. elegans Twist homolog, HLH-8, plays a complex role in transcriptional regulation. Genetics. 2023;224(4). doi: 10.1093/genetics/iyad066 ; PubMed Central PMCID: PMC10411555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.McMiller TL, Sims D, Lee T, Williams T, Johnson CM. Molecular characterization of the Caenorhabditis elegans REF-1 family member, hlh-29/hlh-28. Biochim Biophys Acta. 2007;1769(1):5–19. Epub 20061229. doi: 10.1016/j.bbaexp.2006.12.001 . [DOI] [PubMed] [Google Scholar]
  • 41.Dong MQ, Chase D, Patikoglou GA, Koelle MR. Multiple RGS proteins alter neural G protein signaling to allow C. elegans to rapidly change behavior when fed. Genes & development. 2000;14(16):2003–14. [PMC free article] [PubMed] [Google Scholar]
  • 42.Dy P, Penzo-Mendez A, Wang H, Pedraza CE, Macklin WB, Lefebvre V. The three SoxC proteins—Sox4, Sox11 and Sox12—exhibit overlapping expression patterns and molecular properties. Nucleic Acids Res. 2008;36(9):3101–17. Epub 20080410. doi: 10.1093/nar/gkn162 ; PubMed Central PMCID: PMC2396431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Lefebvre V, Bhattaram P. SOXC Genes and the Control of Skeletogenesis. Curr Osteoporos Rep. 2016;14(1):32–8. doi: 10.1007/s11914-016-0296-1 ; PubMed Central PMCID: PMC4785067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Shen Q, Shi H, Tian C, Ghai V, Liu J. The C. elegans Spalt-like protein SEM-4 functions through the SoxC transcription factor SEM-2 to promote a proliferative blast cell fate in the postembryonic mesoderm. Dev Biol. 2017;429(1):335–42. doi: 10.1016/j.ydbio.2017.06.011 ; PubMed Central PMCID: PMC5554739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Davidson EH, Levine MS. Properties of developmental gene regulatory networks. Proc Natl Acad Sci U S A. 2008;105(51):20063–6. Epub 20081222. doi: 10.1073/pnas.0806007105 ; PubMed Central PMCID: PMC2629280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Kipreos ET, van den Heuvel S. Developmental Control of the Cell Cycle: Insights from Caenorhabditis elegans. Genetics. 2019;211(3):797–829. doi: 10.1534/genetics.118.301643 ; PubMed Central PMCID: PMC6404260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Boxem M, van den Heuvel S. lin-35 Rb and cki-1 Cip/Kip cooperate in developmental regulation of G1 progression in C. elegans. Development. 2001;128(21):4349–59. doi: 10.1242/dev.128.21.4349 . [DOI] [PubMed] [Google Scholar]
  • 48.Korzelius J, The I, Ruijtenberg S, Prinsen MB, Portegijs V, Middelkoop TC, et al. Caenorhabditis elegans cyclin D/CDK4 and cyclin E/CDK2 induce distinct cell cycle re-entry programs in differentiated muscle cells. PLoS Genet. 2011;7(11):e1002362. Epub 20111110. doi: 10.1371/journal.pgen.1002362 ; PubMed Central PMCID: PMC3213155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Park M, Krause MW. Regulation of postembryonic G(1) cell cycle progression in Caenorhabditis elegans by a cyclin D/CDK-like complex. Development. 1999;126(21):4849–60. doi: 10.1242/dev.126.21.4849 . [DOI] [PubMed] [Google Scholar]
  • 50.Ruijtenberg S, van den Heuvel S. G1/S Inhibitors and the SWI/SNF Complex Control Cell-Cycle Exit during Muscle Differentiation. Cell. 2015;162(2):300–13. Epub 20150702. doi: 10.1016/j.cell.2015.06.013 . [DOI] [PubMed] [Google Scholar]
  • 51.Fujita M, Takeshita H, Sawa H. Cyclin E and CDK2 repress the terminal differentiation of quiescent cells after asymmetric division in C. elegans. PLoS One. 2007;2(5):e407. Epub 20070502. doi: 10.1371/journal.pone.0000407 ; PubMed Central PMCID: PMC1852333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Liu J, Fire A. Overlapping roles of two Hox genes and the exd ortholog ceh-20 in diversification of the C. elegans postembryonic mesoderm. Development (Cambridge, England). 2000;127(23):5179–90. doi: 10.1242/dev.127.23.5179 [DOI] [PubMed] [Google Scholar]
  • 53.Muller U, Steinberger D, Kunze S. Molecular genetics of craniosynostotic syndromes. Graefes Arch Clin Exp Ophthalmol. 1997;235(9):545–50. doi: 10.1007/BF00947081 . [DOI] [PubMed] [Google Scholar]
  • 54.Penton AL, Leonard LD, Spinner NB. Notch signaling in human development and disease. Semin Cell Dev Biol. 2012;23(4):450–7. Epub 20120128. doi: 10.1016/j.semcdb.2012.01.010 ; PubMed Central PMCID: PMC3638987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.DeVore DL, Horvitz HR, Stern MJ. An FGF receptor signaling pathway is required for the normal cell migrations of the sex myoblasts in C. elegans hermaphrodites. Cell. 1995;83(4):611–20. doi: 10.1016/0092-8674(95)90101-9 . [DOI] [PubMed] [Google Scholar]
  • 56.Tiwari N, Tiwari VK, Waldmeier L, Balwierz PJ, Arnold P, Pachkov M, et al. Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming. Cancer Cell. 2013;23(6):768–83. doi: 10.1016/j.ccr.2013.04.020 . [DOI] [PubMed] [Google Scholar]
  • 57.Zhang J, Liang Q, Lei Y, Yao M, Li L, Gao X, et al. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. Cancer Res. 2012;72(17):4597–608. Epub 20120711. doi: 10.1158/0008-5472.CAN-12-1045 . [DOI] [PubMed] [Google Scholar]
  • 58.Huang W, Chen Z, Shang X, Tian D, Wang D, Wu K, et al. Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis through up-regulating Twist1 and FGFBP1. Hepatology. 2015;61(6):1920–33. Epub 20150408. doi: 10.1002/hep.27756 . [DOI] [PubMed] [Google Scholar]
  • 59.Levitan D, Greenwald I. LIN-12 protein expression and localization during vulval development in C. elegans. Development (Cambridge, England). 1998;125(16):3101–9. doi: 10.1242/dev.125.16.3101 [DOI] [PubMed] [Google Scholar]
  • 60.Wilkinson HA, Greenwald I. Spatial and temporal patterns of lin-12 expression during C. elegans hermaphrodite development. Genetics. 1995;141(2):513–26. doi: 10.1093/genetics/141.2.513 ; PubMed Central PMCID: PMC1206752. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Barth D Grant, Giovanni Bosco

22 Aug 2024

Dear Dr Liu,

Thank you very much for submitting your Research Article entitled 'SEM-2/SoxC regulates multiple aspects of C. elegans postembryonic mesoderm development' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important problem, but raised some substantial concerns about the current manuscript. Based on the reviews, we will not be able to accept this version of the manuscript, but we would be willing to review a substantially-revised version. We cannot, of course, promise publication at that time.

Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. In particular, while the work is well quantified in parts, other parts of the manuscript makes interpretations about relative reporter fluorescence intensity without quantification of intensity, as noted by reviewer 2. The authors should either further quantify the data and provide intensity measurements with statistical analysis in the relevant figures, or change the language of the claims. This is not necessarily needed when signal is stated to be undetectable, but is important when signal is detectable and claimed to be dimmer or brighter than controls. Reviewers 1 and 3 note areas that require better explanation and revision, such as the section describing promoter deletion analysis. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, log into your Editorial Manager account and select the option 'Revise Submission' in the 'Submissions Needing Revision' folder.

Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Barth D Grant

Guest Editor

PLOS Genetics

Giovanni Bosco

Section Editor

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: This paper describes new roles for the C. elegans SoxC protein SEM-2 during development of a postembryonic mesodermal lineage. The basis of the work is a new allele of sem-2, which is a missense mutation in the DNA binding domain that results in a partial loss of function (by genetic criteria). The authors use this mutation to further explore the function of sem-2 in M lineage specification, adding to their already significant understanding of the gene regulatory networks governing M development. They find that SEM-2 is required for the proliferation and diversification of the SM lineage, acts antagonistically with LET-381/FoxF, and (likely directly) regulates hlh-8/Twist.

This work advances our understanding of the gene regulatory mechanisms governing development of the M mesoblast, which is a postembryonic multipotent progenitor cell. This gene regulatory network may be conserved in metazoans, as homologous genes have been implicated in craniofacial development in humans. The paper is well written. The results are strong and clearly support the conclusions.

Specific points:

1. Line 64. The M mesoblast is described as pluripotent. Pluripotency is the ability to develop into all three germ layers. M is more accurately described as multipotent.

2. Lines 356-359. It wasn’t clear to me why both jj321 and jj152 were examined, as both mutations result in the same amino acid change and all evidence suggests they have the same phenotype.

3. Lines 380-383. This sentence should be revised: “We reasoned that the more robust expression of sem-2 in sem-2(ok2422) null embryos born from [heterozygous] parents is likely due to the maternal contribution of SEM-2 by [heterozygous] parents”. I believe the authors offer an explanation as to why the phenotype of ok2422 is less severe than that of jj152. This needs to be made clearer.

4. Figure 5G-M. It appears that there is more background for the hlh-8::mCherry images in the sem-2 mutant background (H, L’, M’). This may be due to a longer exposure that is required because hlh-8 expression is reduced in the mutants. Exposure differences should be indicated in the figure legend.

5. Lines 485-487. An alternative possibility is that hlh-8 does not depend on SEM-2 at later stages in the M lineage.

Reviewer #2: This manuscript utilizes a novel allele of the SoxC transcription factor, sem-2, isolated in a forward genetic screen. They use a combination of CRISPR genome engineering, traditional transgene reporter analysis and imaging to characterize the phenotype of their sem-2 allele, in the context of the M lineage and the gene regulatory network controlling SM fate, proliferation and differentiation. Their results extend earlier work by their group and others in our understanding of the transcriptional network that underlies the hermaphrodite reproductive musculature.

I have several suggestions where the manuscript could be significantly improved by quantifying images rather than just reporting general trends. The authors did the appropriate quantification for some of their data (Figures 5 & 7), but this quantification is missing from the rest of the manuscript.

Major comments:

- Lines 262-265 – It would be necessary to quantify a series of images acquired using the same settings before concluding that the expression levels are the same between the wild-type and mutant GFP-tagged alleles.

From the micrographs shown in Figure 3 of the endogenous expression and localization of the GFP-tagged SEM-2 allele, it appears that SEM-2 localizes to both the cytosol and nucleus. It might be important to quantify this over developmental time if possible – esp. to see if there are any differences in this localization pattern between the P158S allele. By quantifying this data, the author’s could make a stronger statement, and then the shading in Figure 3L could be a quantitative read-out of the data.

Lines 292-296: In comparing the sem-2::GFP expression in wild-type and sma-9(cc604) backgrounds, it is difficult to assess from a single image – I would recommend quantifying a set of images before making any conclusions about expression levels between different backgrounds.

Figure S2 – I would recommend taking the same approach as you took in Figure 4 for quantifying your data. I would also recommend showing the equivalent expression comparison in panel C/D and then a label showing 20x brighter rather than just putting that information in the figure legend, as it wasn’t immediately obvious to me.

When comparing expression between strains, I would suggest including the quantification rather than just the number of animals examined – for example, in line 357 it states that 100% of mutants displayed reduced expression (100%, N=234).

Instead I would quantify the difference and report it, rather than just the amount of a population that is in the state you are comparing too. This would help with the data and accompanying results in Figure 6 (E-G’’) – I would include quantification of this data, and then report that in the text rather than the % of the population that is indicative of the state (expressing less?

For reporting the proliferation defect in the SM lineage in the sem-2 allele (Figure 8 and accompanying text), I think a summary figure or accompanying plot showing the number of SMs per stage would be appropriate – you could stage animals in sem-2 mutants by VPC divisions.

Discussion –

Line 550-551 – Rather than state that sem-2 might interact with cell cycle regulators interacting with proteins mentioned in a specific review, I would be specific here – possibly through positive regulation of G1/S-phase cyclins and CDKs (Cyclin D/CDK4, Cyclin E/CDK2) or possibly negative regulation of CDK inhibitors like CKIs (CKI-1/CKI-2)?

Minor comments:

Scale bars are missing in the micrographs

For most of the figures, I would recommend showing single color images in grey scale as the human eye can see more details in gray scale than in color. For the overlays, it would be good to avoid red/green combinations as many people are color blind – you could use magenta for red, or any other color-blind friendly look-up-table (LUT) for your overlays. The data was shown this way in some of the figures, but I would recommend doing this for all single channel images, reserving false colors for overlays.

Reviewer #3: 

 Overview: 

This manuscript reports the identification and characterization of a partial loss-of-function allele of the C. elegans SoxC transcription factor SEM-2 that was isolated in a screen for suppressors of a sma-9 mutant that lacks the development of the coelomocytes in the post-embryonic development of the M lineage. The study has led to a new understanding of the relationship between SEM-2, SMA-9 and LET-381 (a FoxF/C forkhead transcription factor) and of the regulation of another transcription factor in the M lineage, HLH-8. The work has mechanistic implications regarding the transcriptional regulation of cell fate during development and potentially in the pathogenesis of disease since these factors are homologs of proteins that are defective in human developmental disorders. 

General comments: 

This manuscript is well-written and the experimental evidence is convincing. The comments outlines below are fairly minor except for the hlh-8 promoter experiment that either needs the approach justified or explained further. 

Specific concerns: 

1. It would be helpful if Fig 1B included some additional information that depicted the relationships between the various proteins described in the introduction and the CC/SM fates that would then be built upon in the Fig 10 model. 

2. The complementation test described in lines 139-141 should define qIs48—is this a GFP reporter (not indicated in the strain table either)? jjIs3900 should be described or explained. And, the isolation of red, non-green animals should be explained as well. 

3. In the Plasmids section of the methods, the purpose of the plasmids should be stated before explaining how the plasmid was made. 

4. In discussing the screen and identification of jj152 (lines 217-223), it is confusing how a single allele can be a complementation group. By definition, a group should contain multiple alleles. Also, it should be stated how the jj152 phenotypes compare with the original sma-9 mutants. 

5. In the results section, it doesn’t make sense how a mutation that is predicted to not touch DNA would affect the DNA binding affinity. Consider rewording or proposing multiple possibilities. 

6. In the experiments where the SoxC binding sites are being investigated in the hlh-8 promoter there are several points that need clarifying in both the figures and the text. It is not clear why deletion assays were performed if two putative sites were initially identified. Why weren’t those sites directly mutated once they were noted in the sequence analysis? Was the point of the deletion studies to see if there were any other sites in the region? Or to see whether the regions surrounding where the sites were located were necessary for hlh-8 expression? This section of the results needs revising with more explanation. Further, it is not clear in the text or in Fig 10, what kind of mutations are being made to site 1 and site 2. Are they deletions? Are they scrambled sites (which are often better since this would maintain the spacing in the promoter)? Fig 10A should be modified to show the mutations or minimally the nature of the mutations should be stated in the legend. And, why were two site 1 mutant strains made and not a site 2 mutant strain made? Finally, in Fig 10, why are the merged panels not yellow (or at least orange) in B” and E”-G” when there appears to be signal in both of the single channels? 

7. I have several other figure labeling suggestions. In Fig 3 G/H there are bright red cells in addition to the SMs, it would be helpful to have arrows marking the SMs. The legend in Figure 4 is confusing and redundant. Instead of labeling the SMs and SM-like cells white in the upper panels and yellow in the lower panels and describing them twice in the legend, just be consistent with labeling all the panels and define those labels one time in the legend. 

Minor concerns and edits (with line numbers indicated): 

99 and 608: “Coffin-Siris syndrome (CSS)” 

125: “Fiji” should either be explained or have a website indicated 

128: software used for statistical analysis should be indicated 

152 change “give” to “produce” 

153 and throughout manuscript: wild type should be two words and have a dash if modifying a noun such as wild-type animals 

164: the plasmids are listed in Supp Table 3 and not 2 (fix the table numbers in lines 194 and 195 as well) or swap the tables since the text doesn’t match the actual supplementary table numbers. 

166: define IDT 

196: pRF4 not PRF4 

229: indicate the specific transgene (jjIs1647?) 

230: Tian et al. 2011 stated here and in the discussion should be numbered like the other references. 

266: say “This prediction is consistent with our genetic…” 

314: after sma-9 (0) animals add (Fig 4E-H’’’) 

406: “Similarly, in 50%...” 

419: HLH-8 (8 not in italics) and Fig 7 A-M fix since there is no M in the figure 

421: “in the vms (Fig 7 B, B’). Further, 95% sem-2…” 

423: the text states that the mutants were variable but the Fig 7G shows a large standard deviation for WT, too, so needs revising 

435: “At the late L4…” 

562: arg-1::gfp should be in italics 

588: P158S should not be in italics 

814: “…Egl phenotype with a uterus filled with late-stage embryos” 

820/822: “A) [Top] Schematic of the …” and “…by an asterisk. [Bottom] Sequence alignment.” 

882: “…mutant animal (L-M”),…” 

897: “images” 

926: WT should not be listed as a sem-2 mutant in A,C,E 

940: “C”-H” are merged images” 

954-955: fix the excess italics 

Multiple figure legends have “fluorescence” misspelled. 

In Supp Table 2, last row—pMDB37 “Repair template for generating..” should not be in italics 

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Attachment

Submitted filename: ReviewercommentsBaccasetalPLoS.pdf

pgen.1011361.s010.pdf (83.6KB, pdf)

Decision Letter 1

Barth D Grant, Giovanni Bosco

5 Nov 2024

Dear Dr. Liu,

We are pleased to inform you that your manuscript entitled "SEM-2/SoxC regulates multiple aspects of C. elegans postembryonic mesoderm development" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made. The reviewers have pointed out some typos and misplaced citations that should also be corrected.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Barth D Grant

Guest Editor

PLOS Genetics

Giovanni Bosco

Section Editor

PLOS Genetics

Aimée Dudley

Editor-in-Chief

PLOS Genetics

Anne Goriely

Editor-in-Chief

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The authors have addressed all of the reviewers' critiques. The manuscript is improved by the revision. The work clearly advances our understanding of the gene regulatory mechanisms governing development of a mesodermal progenitor cell in C. elegans. It may also be more broadly relevant to human craniofacial development, as the same genes are important for both processes.

Reviewer #2: I commend the authors for integrating all three reviewer comments into the much improved manuscript and appreciate the efforts to present quantified data - I think it strengthens arguments! My only comment is there a typo - "CKD" instead of "CDK" in line 589 p.24.

I would stress the importance of not showing red/green images in your figures - for anyone who is red/green colorblind those overlays and images will be uninterpretable. In ImageJ/FIJI there is a setting to swap out red for magenta - so in theory this would be an easy fix and not require you to remake all your figures.

Reviewer #3: Baccas and colleagues have submitted a substantially revised version of their manuscript with additional experimental data and corresponding text edits. The concerns that I expressed in the initial review have been adequately addressed. I'll note that the file for the revised version did not contain the two Tables found in the initial submission, but I assume the Tables didn't change so I am not concerned about that. On line 582, where the reference has been corrected to be [6], the original reference, Tian et al, 2011, is still in the text and should be deleted. And the new figure legends where "Data is normalized..." is stated should instead read "Data are normalized..." Otherwise, I have no further concerns about the quality of this work.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-24-00741R1

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Acceptance letter

Barth D Grant, Giovanni Bosco

8 Jan 2025

PGENETICS-D-24-00741R1

SEM-2/SoxC regulates multiple aspects of C. elegans postembryonic mesoderm development

Dear Dr Liu,

We are pleased to inform you that your manuscript entitled "SEM-2/SoxC regulates multiple aspects of C. elegans postembryonic mesoderm development" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Livia Horvath

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. C. elegans strains used in this study.

    (DOCX)

    pgen.1011361.s001.docx (21.7KB, docx)
    S2 Table. Plasmids generated in this study.

    (DOCX)

    pgen.1011361.s002.docx (17.1KB, docx)
    S3 Table. Oligonucleotides used in this study.

    (DOCX)

    pgen.1011361.s003.docx (18.6KB, docx)
    S1 Fig. Quantification of GFP::2xFLAG::SEM-2 expression during M lineage development.

    A–C) Quantification of GFP::2xFLAG::SEM-2 fluorescence intensity in the nuclei (A, D, G), the cytoplasm (B, E, H), and the ratio of nuclear signal to cytoplasmic signal (C, F, I) in the early M lineage (A, B, C), the SM lineage (D, E, F), and throughout M lineage development (G, H, I). All images were taken at the same exposure and same magnification. Each dot represents a cell scored. Data for GFP::2xFLAG::SEM-2 expression at the 16-M stage in M-derived BWMs and SM mother cells are denoted 16-M(B) and 16-M(S), respectively. For graphs D-I, only data for the SMs at the 18-M stage are shown. For panels C, F, and I, the ratios were calculated by dividing the nuclear GFP intensity by the cytoplasmic GFP intensity. For panels A–C, data were normalized to the 1-M stage. For panels D–I, data were normalized to the 18-M stage. Statistical analysis was done using one-way ANOVA with Dunnett’s test. **** P<0.0001, *** P<0.001, ** P<0.01, * P<0.05, ns, not significant. All the corresponding data shown in panels A-C and D-F were combined and shown in panels G-I. To prevent the graph from being too crowded, only P values not shown in panels A-F are shown in G-I. There is a gradual decrease in the level of nuclear GFP::2xFLAG::SEM-2 in the early M lineage after the 2-M stage (A). At the 16-M stage, there is an upregulation of nuclear GFP::2xFLAG::SEM-2 in the SM mothers (A). At the 18-M stage, this increase in nuclear GFP::2xFLAG::SEM-2 persists in the SMs but becomes undetectable in the BWMs (including in the SM sister cells, which transiently express GFP::2xFLAG::SEM-2) upon terminal differentiation. There is then a gradual decrease in the level of nuclear GFP::2xFLAG::SEM-2 signal in the SM descendants (D). The level of cytoplasmic GFP::2xFLAG::SEM-2 signal appears relatively stable within the early M lineage (B), and within the SM lineage (E). The ratio of nuclear to cytoplasmic localization of GFP::2xFLAG::SEM-2 in the M lineage follows the pattern of change of nuclear GFP::2xFLAG::SEM-2 (C, F, I). There is an increase in the level of nuclear and cytoplasmic GFP::2xFLAG::SEM-2, as well as their ratio, in the SMs at the 18-M stage compared with the M mesoblast cell at the 1-M stage (G, H, I).

    (TIF)

    pgen.1011361.s004.tif (3.3MB, tif)
    S2 Fig. Quantification of GFP::2xFLAG::SEM-2 expression in the M lineage of wild-type and SEM-2 P158S mutant animals.

    A–B”) Fluorescence images showing GFP::2xFLAG::SEM-2 (A’–B’) in the M mesoblast cell labelled by the hlh-8p::nls::mCherry reporter (A–B) at the 1-M stage in WT (A–A”) and sem-2(jj417[SEM-2 P158S]) (B–B”) hermaphrodites. (A”–B”) are the corresponding merged images. The GFP::2xFLAG::SEM-2 images were taken at the same exposure and same magnification. C–E) Quantification of GFP::2xFLAG::SEM-2 in the nuclei (C), the cytoplasm (D), and the ratio of nuclear to cytoplasmic signal (E) in the M mesoblast cell of wild-type and sem-2(jj417[SEM-2 P158S]) animals. F–I”) Fluorescence images of a wild-type (sem-2(jj382)) animal (F–G”) and a sem-2(jj417[P158S]) mutant animal (H–I”), showing GFP::2xFLAG::SEM-2 (F’–I’), hlh-8p::nls::mCherry (F–I), and the corresponding merged images (F”–I”) in the two SMs. All GFP::2xFLAG::SEM-2 images were taken at the same exposure and same magnification, while hlh-8p::nls::mCherry images in H and I were taken using a longer exposure than those in F and J. J–L) Quantification of GFP::2xFLAG::SEM-2 in the nuclei (J), the cytoplasm (K), and the ratio of nuclear to cytoplasmic signal (L) in the SMs of wild-type and sem-2(jj417[SEM-2 P158S]) animals. For panels E and L, the ratios were calculated by dividing the nuclear GFP intensity by the cytoplasmic GFP intensity. Each dot represents a cell scored. Data are normalized to WT. Statistical significance was calculated by performing unpaired two-tailed Student’s t-tests. *** P<0.001, * P<0.05, ns, not significant. Scale bars represent 10 μm. Arrows point to the M mesoblast cell, while arrowheads point to the SM cell.

    (TIF)

    pgen.1011361.s005.tif (12.4MB, tif)
    S3 Fig. sem-2 expression in the early M lineage does not change in sma-9(0) mutants.

    A–D”) Fluorescence images showing GFP::2xFLAG::SEM-2 (A’–D’) in M lineage cells labelled by the hlh-8p::nls::mCherry reporter (A–D) at the 2-M stage (A–B”) and 8-M stage (C–D”) of M lineage development in WT (A–A”, C–C”) and sma-9(0) (B–B”, D–D”) hermaphrodites. (A”–D”) are the corresponding merged images. Only the left side of an animal is shown in this figure, while the other side is out of the focal plane. Scale bar represents 20 μm. E–G) Quantification of GFP::2xFLAG::SEM-2 in the nuclei (E), the cytoplasm (F), and the ratio of nuclear to cytoplasmic signal (G) in the early M lineage of WT and sma-9(0) mutants. For panel G, the ratios were calculated by dividing the nuclear GFP intensity by the cytoplasmic GFP intensity. Each dot represents a cell scored. Data are normalized to WT at the 1–2 M stage. Statistical significance was calculated by performing unpaired two-tailed Student’s t-tests. ns, not significant.

    (TIF)

    pgen.1011361.s006.tif (10.6MB, tif)
    S4 Fig. The regulation of hlh-8 by SEM-2 is not transgene- or sem-2 allele-specific.

    A–B”) Fluorescence images (A–B) of wild-type (A–A”) and sem-2(jj321[P158S]) (B–B”) embryos showing the expression of hlh-8p::nls::mCherry in the M mesoblast cell (arrows). A’–B’ and A”–B” are corresponding DIC and merged images, respectively. Transgenic animals expressing hlh-8p::nls::mCherry were generated with a co-injection marker myo-2p::mCherry represented by the red pharyngeal signal. Scale bar represents 15 μm. C) Quantification of hlh-8p::nls::mCherry expression in the M mesoblast cell of WT and sem-2(jj321[P158S]) embryos. Each dot represents an embryo scored. Data are normalized to WT. Statistical significance was calculated by performing unpaired two-tailed Student’s t-tests. * P<0.05. D–E) Fluorescence images of wild-type (D–D”) and sem-2(jj152[P158S]) (E–E”) mutant L3 animals showing expression of the hlh-8p::gfp transgene in SMs. D’–E’ and D”–E” are corresponding DIC and merged images, respectively. Exposure for panel E is 20x times higher than panel D (1x). Scale bar represents 10 μm. F–G) Fluorescence images of wild-type (F) and sem-2(jj152[P158S]) (G) mutant L1 animals at the 4-M stage showing expression of the hlh-8p::gfp transgene at the same exposure (1x). Scale bar represents 20 μm. H–I”) Fluorescence images (H–I) of a heterozygous sem-2 null (sem-2(ok2422)/hT2[qIs48]) (H–H”) and a sem-2 null (sem-2(ok2422)) (I–I”) embryo showing expression of hlh-8p::nls::mCherry. myo-2p::gfp images from the hT2[qIs48] balancer chromosome are shown in H’–I’ and merged images are shown in H”–I”. Scale bar represents 15 μm. J) Quantification of hlh-8p::nls::mCherry expression in the embryonic M mesoblast cell of sem-2(ok2422)/hT2[qIs48] and sem-2(ok2422) animals. Each dot represents an embryo scored. Data are normalized to sem-2(ok2422)/hT2[qIs48]. Statistical significance was calculated by performing unpaired two-tailed Student’s t-tests. ns, not significant. K–L”’) Fluorescence images (K–L) of a heterozygous sem-2 null (sem-2(ok2422)/hT2[qIs48]) (K–K”’) and a sem-2 null (sem-2(ok2422)) (L–L”’) L1 animals showing expression of hlh-8p::nls::mCherry. myo-2p::gfp images from the hT2[qIs48] balancer chromosome are shown in K’–L’, merged images of hlh-8p::nls::mCherry and myo-2p::gfp are shown in K”–L”, and DIC images are shown in K”’–L”’. Scale bar represents 20 μm. Arrows point to M lineage cells.

    (TIF)

    pgen.1011361.s007.tif (15.4MB, tif)
    S5 Fig. The putative SEM-2/SoxC-binding site in E1 is conserved.

    A) Screenshot of the University of California, Santa Cruz (UCSC) genome browser showing the sequence conservation of E1 and E2 in the hlh-8 promoter among 26 nematode species and a broader 135 species (112 nematodes, 22 flatworms, and Ciona intestinalis). The magenta color highlights E1 and E2. Red boxes show Site1 and Site2. The yellow color highlights the putative SEM-2/SoxC-binding sites in E1/Site1 and E2/Site2. B) The position weight matrix of the Sox4/SoxC primary motif as determined by the protein-binding microarray (PBM) method [33].

    (TIF)

    pgen.1011361.s008.tif (11.9MB, tif)
    S1 Data. Excel file containing all the raw data for Figs 2, 5, 6, 7, S1, S2, S3 and S4.

    (XLSX)

    pgen.1011361.s009.xlsx (39.6KB, xlsx)
    Attachment

    Submitted filename: ReviewercommentsBaccasetalPLoS.pdf

    pgen.1011361.s010.pdf (83.6KB, pdf)
    Attachment

    Submitted filename: Baccas et al-response to reviewers-10-5-24.pdf

    pgen.1011361.s011.pdf (157.5KB, pdf)

    Data Availability Statement

    Strains and plasmids are available upon request. The authors affirm that all data necessary for confirming the conclusions of the article are present within the article and its supporting information files.


    Articles from PLOS Genetics are provided here courtesy of PLOS

    RESOURCES